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ABSTRACT 
 
 Membrane proteins are essential for the cell to communicate with its environment. 
They function as a gateway across the lipid bilayer, allowing stimuli transmission and 
controlling molecular transport into or out of the cell. The structure of membrane proteins 
plays a pivot role in their function and mechanism. However, determination of membrane 
protein structure remains a great challenge due to difficulties associated with expression and 
purification. This dissertation focuses on utilizing X-ray crystallography to study the 
structure and the function of various membrane proteins from different biological systems. 
Chapter 2 explores the role of MmpL family transporters in the development of antibiotic 
resistance in Mycobacterium tuberculosis. The cell wall of M. tuberculosis is crucial to its 
virulence and antimicrobial resistance. The MmpL transporters are known to participate in 
cell wall formation by exporting fatty acid derivatives. We present the structural insights into 
the TetR transcriptional regulator Rv0302, which controls the expression of several MmpL 
proteins. Also, by combining functional studies and structural analysis, we demonstrate how 
the investigation of Rv0302 improves our understanding of substrate transport by the MmpL 
family proteins. Chapter 3 details our investigations of the the carbon concentrating 
mechanism (CCM) of the green algae Chlamydomonas reinhardtii. Due to their aquatic 
habitat, the photosynthetic efficiency of phytoplankton is hindered by the difficulty of 
maintaining sufficient supply of inorganic carbon (Ci). To overcome this hurdle, these 
microorganisms have developed CCM to enhance Ci uptake from its Ci limited environment. 
We reveal the structure of a CCM related membrane protein transporter LCI1, whose 
structure is the first membrane transporter solved in the CCM pathway of C. reinhardtii and 
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is unique in the protein database. Finally, in chapter 4 we apply our knowledge of protein 
crystallography to study plant receptor-like kinase FERONIA from Arabidopsis thaliana. 
FERONIA is known to play an important role in many plant signaling pathways such as 
growth development, root growth, and drought response. We demonstrated different 
expression, purification and crystallization attempts of acquiring structural information of 
FERONIA and the plant hormones RALF1 and RALF23. While these efforts did not result in 
a solved structure, based on our acquired experience with this system, we suggest several 
directions for future structural study of membrane protein in higher evolved organisms. 
 
   
1 
 
CHAPTER I 
GENERAL INTRODUCTION 
Proteins are the most versatile macromolecules present in living organisms and essential 
to nearly all the biological activities. By interacting with other proteins, they perform various 
tasks to sustain biological processes, including catalysis, molecular transport, signaling, and 
structural element formation. In general, proteins are composed of a sequence of polymerized 
amino acids, which fold into a specific structure that defines the function of the protein. Thus, to 
understand the function of the proteins, it is crucial to obtain their structural information. 
Currently, there are three major approaches for protein structure determination, which include 
nuclear magnetic resonance spectroscopy (NMR), X-ray crystallography, and cryo-electron 
microscopy. To date, X-ray crystallography has been the most reliable s technique for solving 
protein structure. Up to now, more than 120,000 structures have been deposited to PDB and 90% 
of the protein structures are determined by X-ray crystallography 
(http://www.rcsb.org/pdb/statistics/holdings.do). 
           Since the first protein structure was determined half a century ago (myoglobin at 6 Å 
resolution),1 X-ray crystallography has been the chief method for protein structure determination 
and the procedure of macromolecule crystallization has been standardized and described in great 
detail in many textbooks.2,3,4 In short, the proteins of interested are prepared by extracting them  
directly from the native organisms or purifying the recombinant protein by heterogeneous 
expression in various expression systems such as well-established bacterial expression host 
Escherichia coli, or in a variety of eukaryotic cells. To ensure the homogeneity of samples, the 
proteins are then further polished by size exclusion chromatography (SEC) or ion exchange 
chromatography (IEC) and then subjected to crystallization screens. Protein crystallization is 
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most often achieved by the vapor diffusion method5,6. This method allows proteins to slowly 
reach the supersaturation and thus induces crystallization by equilibrating a droplet of the 
purified protein mixed with crystallization solution containing precipitants, salts, buffers, and 
additives, with a large reservoir with the similar crystallization solution at a higher concentration. 
By changing the combination and concentration of the components in the crystallization solution, 
the protein crystals can be optimized for suitable quality and size for data collection. 
           Thanks to the development of both software and hardware in data collection of protein X-
ray crystallography,7,8,9,10 the time required for collecting diffraction data has been greatly 
reduced. However, a significant amount of crystal screening to acquire the best resolution data 
and experimental phase information is inevitable. Phase solving is essential to 3D electron 
density reconstitution in protein crystallography since the diffraction patterns provide only the 
intensity of the reflections. Phases are crucial to calculate the structural function in diffraction 
theory. There are several approaches to obtain the phase information of protein crystals, 
including acquiring anomalous signals to break Friedel’s law (Single/Multiple anomalous 
dispersion (SAD/MAD)),11 simplifying the diffraction patterns by introducing electron-rich 
(heavy) atoms into crystals (Single/Multiple isomorphous replacement (SIR/MIR)),11,12 matching 
the Patterson function with an existing model (Molecular replacement),13 direct method 
(applicable only for small peptides) and the combination of different methods (Single 
isomorphous replacement with anomalous signal (SIRAS)). Once the phase problem is solved, 
the protein model can be built based on the electron density map that reconstituted from the 
diffraction data and thus the reveals structure of the protein. Currently, there are many program 
packages available such as CCP414 and Phenix,15 providing software for phase solving, model 
refining, and model building.  
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            Despite the success in a variety of proteins, membrane protein structure determination is 
still a great challenge to X-ray crystallography. Among 70,000 unique protein structures in PDB, 
only less than 1% of them are membrane proteins (http://blanco.biomol.uci.edu/mpstruc/). 
Membrane proteins, which make up around 30% of all genes,16,17 are proteins that associate with 
or embed in the cell membrane. Some function as the bridges across the lipid bilayer, allowing 
stimuli transmission and molecular transport into or out of the cell. Also, more than 50% of 
modern drugs target membrane proteins,18 which makes the structural information of these 
proteins valuable to drug development. However, structural and functional studies of membrane 
proteins are often limited by difficulties in expression, purification, and crystallization.19 
            Due to the low copies of membrane proteins in their native environment, recombinant 
overexpression is necessary to obtain a suitable quantity for crystallization. Membrane proteins 
are stable and well-folded only in the environment that is similar to their native environment. 
Also, membrane proteins, especially eukaryotic proteins are often modified by post-translational 
modification (PTM), including phosphorylation and glycosylation. Thus, choosing the 
appropriate expression host according to the properties of the target protein is important to 
acquire high quality recombinant protein.20 To date, several expression systems have established 
for membrane protein expression, including E. coli, yeast (S. cerevisiae,21 Pichia22), insect cells 
(Sf9, Hi5),23 and mammalian cells (HEK293).24 
            For membrane protein purification and crystallization, detergents are essential to extract 
proteins from lipid bilayer and stabilize proteins in the buffer by protecting the hydrophobic 
transmembrane domains from exposure to the solution. Generally, detergents used for membrane 
protein crystallization are an alkyl-chain between 7 and 14 carbons in length with varying 
headgroups.25 Among all the detergents, n-dodecyl-D-maltoside (DDM) and n-decyl-D-
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maltoside (DM) are the most common for protein extraction.19 The use of detergents for protein 
extraction can be hinder protein crystallization. Generally, membrane proteins are more stable in 
detergents with longer alkyl-chain. These detergents occupy more space around the protein, 
which prevents it from interacting with another protein and thus prevent crystal packing. 
Therefore, detergent screen through gel filtration is important for optimizing the protein 
condition before being subjected to crystal screen. The choice of an appropriate detergent 
remains empirical, largely depending on the biochemical and structural properties of the target 
proteins.  
            Another strategy to crystallize membrane protein is lipid-protein co-crystallization 
Introducing lipids increases the protein stability by mimicking the native membrane environment 
and thus improves crystal packing. Several related methods have been reported, including adding 
lipids throughout protein purification and crystallization,26 bicell,27 and lipid cubic phase.28,29  
            This dissertation focuses on utilizing X-ray crystallography to study the function and the 
structure of membrane proteins in different biological systems, including bacterial drug 
resistance in Mycobacterium tuberculosis, Carbon Concentrating Mechanism (CCM) green algae 
in Chlamydomonas reinhardtii, and plant receptor-like kinase FERONIA in Arabidopsis thaliana. 
The brief introduction to these projects is described below.  
 
Chapter II  
           For over a century, antimicrobial therapies have been the most effective ways for treating 
bacterial infections. Recently, however, these treatments have been complicated by the fast 
development of bacterial drug resistance. The bacterial resistance to antibiotics can be 
categorized into four major causes, which include alternating drug targeting site, enzymatic 
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degradation, decreased drug permeability by cell wall modification, and drug efflux by active 
transport.30,31 In Mycobacterium tuberculosis, which infects a third of the population and causes 
more than 1 million deaths each year worldwide,32 the drug resistance is related to its unique cell 
wall.33 The cell wall of M. tuberculosis comprises mycolic acids, which can only be found in 
Mycobacterium and play a crucial role in the virulence and antimicrobial resistance.34,35,36 
Biosynthesis of this cell wall is facilitated by the Mycobacterium membrane protein large 
(MmpL) transporters,37 which belong to the resistance-nodulation-cell division (RND) 
superfamily.38 Previous studies have shown that these MmpL transporters are responsible for 
transporting fatty acid and lipid components of the cell wall.39,40,41,42 However, the regulation of 
MmpL protein expression and the role of MmpL proteins in cell wall remodeling has not been 
explored. In this chapter, we provide the structural insights that increase our understanding of the 
regulatory mechanism of TetR regulator Rv0302. We also study the regulation of MmpL 
proteins by Rv0302 with different biochemical and biophysical approaches. Moreover, we 
identify palmitic acid, a precursor of mycolic acids, is a possible natural ligand of Rv0302. 
 
Chapter III 
            During photosynthesis, the essential element carbon is converted from the inorganic form, 
carbon dioxide (CO2), to carbohydrates by the carbon assimilation pathway. Since the carbon 
fixation enzyme Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) has low affinity 
for CO2 and slow carboxylation rate,43,44,45,46 it is important for photosynthetic organisms to 
assure the concentration of CO2 in the cell to maintain the photosynthetic efficiency. However, 
phytoplankton, which contribute more than half of total photosynthetic activity on Earth, find it 
difficult to retain the inorganic carbon (Ci) due to their aquatic habitats, where the CO2 diffusion 
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rate is 10,000 times slower than the rate in air. To adapt to this hazardous environment, these 
microorganisms have developed the Carbon Concentrating Mechanism (CCM) to enhance Ci 
uptake from the Ci limited surrounding.47,48,49,50  
            In unicellular green algae Chlamydomonas reinhardtii, three membrane proteins involved 
in CCM have been characterized, including a bicarbonate (-HCO3) channel LCIA in Formate-
Nitrate Transporter (FNT) family,51,52 a ATP binding cassette (ABC) transporter HLA3,53,54,55 
and a putative transporter LCI1.56,57 HLA3 and LCIA, which are located at the plasma membrane 
and chloroplast membrane respectively, have been found to transport -HCO3 cooperatively into 
chloroplast envelope.58 However, LCI1, whose transformant has shown the increase of Ci uptake 
in C. reinhardtii, appears to represent a completely novel type of transporter. In this chapter, we 
present the crystal structure of novel membrane protein LCI1, which is also the first structure of 
CCM in C. reinhardtii, and provide the structural perspectives of elucidating its transport 
mechanism. 
 
Chapter IV 
           Plant receptor-like kinase FERONIA of Arabidopsis thaliana is known to play an 
important role in many plant signaling pathways such as growth development,59,60 root 
growth,61,62 and drought response.60,63 FERONIA belongs to receptor-like kinase superfamily 
(RLK),64 a group of single transmembrane proteins which consist of an extracellular sensory 
domain and a cytoplasmic kinase domain that phosphorylates their downstream objects to 
activate the response pathways of incoming signals. The sensory of FERONIA is found to 
possesses two malectin-like domains, a homolog domain of animal sugar binding protein that 
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interacts with various sugars. RALFs, a group of plant growth peptide hormones which involve 
in root growth response,65,66 are believed to be the ligands of FERONIA.67 However, the ligand 
sensing mechanism of FERONIA remains elusive due to the lack of the structural information. In 
addition, a drought response related transcription factors RD2668 is activated by FERONIA 
kinase domain. In this study, we investigated the efficiency of different expression and 
purification methods to acquire suitable amounts of protein for crystallization of FERONIA 
sensory domain and plant hormones RALF1 and RALF23. In addition, we purified and 
crystallized the protein kinase domain of FERONIA and DNA binding domain of RD26.  
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Introduction 
Tuberculosis (TB) is a leading cause of death due to infectious disease despite the 
availability of antitubercular drugs. Its causative agent, Mycobacterium tuberculosis (Mtb), 
infects more than one third of the world's population.1 The unique architecture of the 
mycobacterial cell wall plays a key role in the host–pathogen interface since it is associated with 
the Mtb pathogenesis and provides a barrier against environmental stresses, antibiotics, and the 
host immune response. The outer membrane contains an inner leaflet of very long chain mycolic 
acids covalently bound to the arabinogalactan–peptidoglycan layer and an outer leaflet composed 
of noncovalently associated lipids, such as phthiocerol dimycocerosate, sulfolipids, and trehalose 
6,6′!dimycolate.2 These surface!exposed lipids are immunomodulatory and play a role in host–
pathogen interactions.3,4,5,6,7,8 
Recent work demonstrated that the mycobacterial membrane protein large (MmpL) 
proteins are cell wall lipid transporters. The MmpL transporters are crucial contributors to 
mycobacterial physiology and pathogenesis. MmpL3 is essential; MmpL4, MmpL5, MmpL7, 
MmpL8, MmpL10, and MmpL11 are required for full Mtb virulence.9,10,11,12 MmpL3 transports 
the trehalose dimycolate (TDM) precursor trehalose monomycolate to the mycobacterial 
surface.12 MmpL3 is therefore essential since TDM biosynthesis and incorporation into the 
mycobacterial cell wall is required for mycobacterial replication and viability.13,14 
Based on the genomic sequence of H37Rv,15 Mtb harbors 14 different MmpL proteins, 
belonging to the resistance!nodulation!cell division (RND) superfamily of transporters.16 Similar 
to the RND efflux pumps of Gram!negative bacteria, several of these MmpL transporters appear 
to work in conjunction with smaller accessory proteins called mycobacterial membrane protein 
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small (MmpS).9,17,18 However, unlike other RND family proteins, the MmpL proteins are not 
believed to export antibiotics.9 Instead, there is strong evidence that these MmpL transporters 
and their MmpS accessory proteins are responsible for shuttling fatty acid and lipid components 
of the cell wall, such as trehalose monomycolate, sulfolipids, phthiocerol dimycocerosate, 
diacyltrehalose, monomeromycolyl diacylglycerol, and mycolate wax ester.3,9,11,12,19,20,21,22 
The regulation of MmpL protein expression and the role of MmpLs in cell wall 
remodeling in different environmental conditions has not been explored. Thus, we capitalized on 
data made available by the TB Systems Biology Consortium to begin an in!depth analysis of 
how mmpL and mmpS genes are regulated. Currently, chromatin immunoprecipitation 
sequencing (ChIP!Seq) data for 82 of the 180+ Mtb transcription factors is available on the 
TBDatabase (TBDB).24,25,26,27 We recently demonstrated that the MarR!family regulator Rv0678 
regulates the mmpS2!mmpL2, mmpS4!mmpL4, and mmpS5!mmpL5genes. We also identified that 
the crystal structure of Rv0678 is bound with a fatty acid glycerol ester 2!palmitoylglycerol 
(C21H42O4), suggesting that fatty acids may be the natural ligands of this regulator.28 This 
structure has allowed us to elucidate the induction mechanism, where the induced 
conformational change leading to substrate!mediated derepression is primarily caused by a rigid 
body rotational motion of the entire DNA!binding domain of the regulator toward the 
dimerization domain.28  
In this article, we report crystal structures of two conformational forms of the TetR!
family transcriptional regulator Rv0302, which has predicted regulatory interactions within 
the mmpL3 and mmpL11 loci. Binding of this transcriptional regulator to the promoter and 
intragenic regions of mmpL genes is summarized in Figure 1. Typically, the TetR!family 
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regulators are all helical dimeric proteins, consisting of a smaller N!terminal DNA!binding 
domain and a larger C!terminal regulatory domain.29,30 The N!terminal domains are quite 
conserved in protein sequences and form a helix!turn!helix (HTH) motif for DNA binding. 
However, the C!terminal sequences are poorly conserved, forming ligand!specific binding 
domains for inducing molecules. Our crystal structures of Rv0302 suggest that ligand binding at 
the C!terminal regulatory domain triggers a rotational motion of the regulator. This motion 
results in inducing the expression of the MmpL transporters by releasing the Rv0302 regulator 
from cognate DNAs. Using fluorescence polarization and electrophoretic mobility shift assay 
(EMSA), we demonstrate that Rv0302 can bind the promoter regions of these mmpL genes 
within a nanomolar range. 
 
 
Figure 1.  Schematic depiction of Rv0302 binding sites in the mmpL genes of interest. 
ChIPSeq data were obtained from TBDB (www.tbdb.org). In these experiments, FLAG!
tagged (DYKDDDDK) transcription factors were episomally expressed in Mtb under the 
control of an anhydrotetracycline!inducible promoter (Galagan et al.). The red circles 
corresponding to the Rv0302 transcription factor are placed at the putative binding sites. 
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Results and discussion  
Overall structure of Rv0302 
M. tuberculosis Rv0302 is a 210 amino acid (aa) protein that belong to the TetR family of 
transcriptional regulators. Two distinct conformations of Rv0302 with space groups P6122 (form 
I) and P212121 (form II) were captured in two different forms of crystals. The form I structure 
was determined to a resolution of 2.04 Å using single isomorphous replacement. The form II 
conformation was resolved to a resolution of 2.65 Å using molecular replacement with 
anomalous scattering using the form I structure as a search model (Table 1 and Fig. 2). By 
applying the crystallographic symmetry operators, a dimeric arrangement of the structure was 
found. In the form II structure, two monomers were found in the asymmetric unit arranged as a 
dimer. Overall, the architecture of these two Rv0302 structures are in good agreement with those 
of the TetR!family regulators, including TetR,31,32 QacR,33,34 CprB,35 EthR,36,37  
CmeR,38,39 AcrR,40 SmeT,41 Rv3066,42 and Rv1219c.43 
Each subunit of Rv0302 is composed of nine helices (α1–α9 and α1′–α9′, respectively) 
that are organized to form two functional motifs: the N!terminal DNA!binding and C!terminal 
ligand!binding domains (Fig. 3). The helices of Rv0302 are designated numerically from the N!
terminus as α1 (residues 14–29), α2 (residues 37–44), α3 (residues 48–55), α4 (residues 58–76), 
α5 (residues 88–104), α6 (residues 107–117), α7 (residues 123–147), α8 (residues 154–181), and 
α9 (residues 188–208). In this arrangement, the smaller N!terminal DNA!binding domain 
includes helices α1 through α3 and the N!terminal end of α4 (residues 58–65), with α2 and α3 
forming a typical HTH motif. However, the larger C!terminal ligand!binding domain comprises 
21 
 
the C!terminal end of helices α4 (residues 66–76) through α9. Helices α6, α8, and α9 are 
involved in the dimerization of the regulator, and helix α9 contacts both α8 and α9′ to secure the 
dimerization interface. 
In both form I and form II structures, the 21 aa helix α9 folds uniquely along the top of 
the dimer, forming the ceiling for the ligand!binding domain. To make space for this fold, helix 
α8 is oriented at an approximate 25° angle away from the dimerization interface. Comparing the 
dimeric structures of forms I and II suggests that these two structures depict two different 
transient states of the regulator. Superimposition of the forms I and II dimeric structures of 
Rv0302 results in an overall rms deviation of 3.0 Å. The difference between the two 
conformations is a 9° rotational motion of the right subunit with respect to the left protomer 
(Fig. 4). Based on this structural information, it is likely that ligand binding triggers a rotational 
motion within the dimer of the regulator. Presumably, this movement prohibits the binding of the 
dimeric regulator to its cognate DNA, which in turn releases the regulator from the promoter 
region and allows for the expression of the corresponding MmpL transporters. If this is the case, 
then the form I conformation should correspond to the ligand induced form of the Rv0302 
regulator. 
The C!terminal regulatory domain of each subunit of the Rv0302 structures forms a large 
cavity, presumably creating a ligand!binding pocket of the regulator. This cavity, which is 
predominately formed by helices α4–α9, orients more or less vertically and in parallel with the 
twofold symmetry axis of the dimer. At least 24 amino acids line the wall of this cavity. Among 
them, eight are aromatic residues (F73, F74, W80, F112, Y113, F140, Y176, and Y192), 11 are 
hydrophobic residues (I77, L95, L98, L109, V132, A136, L137, L147, V169, and L199), and 
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five are polar or charged residues (S91, Q94, Q102, S143, and D173). Based on these 
observations, ligand binding in Rv0302 is predominately governed by hydrophobic interactions. 
An extra electron density was found within the ligand!binding pocket of each subunit of 
the form I structure of Rv0302 [Fig. 5(A)]. The shape of this extra density is compatible with an 
isopropanol molecule. This was not surprising because we used solutions containing isopropanol 
for crystallization. Each bound isopropanol molecule is completely buried in the Rv0302 binding 
pocket. Four aromatic and hydrophobic residues (L109, F112, Y113, and V132) make 
hydrophobic contacts with the bound isopropanol [Fig. 5(B)]. In addition, one of the side chain 
oxygens of D173 forms a hydrogen bond with the hydroxyl oxygen of the bound isopropanol to 
secure the binding. 
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Figure 2.  Electron density maps of the M. tuberculosis Rv0302 regulator. (A) Stereo view of the 
experimental electron density map of the form I structure at a resolution of 2.04 Å. The electron 
density map is contoured at 1.0σ. The Cα traces of the Rv0302 molecule in the asymmetric unit is 
colored green. Anomalous signals of the two Ta6 cluster sites (contoured at 3σ) found in the 
asymmetric unit are colored red. (B) Representative section of electron density in the vicinity of 
helices α4 and α7. The solvent!flattened electron density (40–2.04 Å) is contoured at 1.0σ and 
superimposed with the final refined model (green, carbon; red, oxygen; blue nitrogen; yellow, sulfur). 
(C) Stereo view of the electron density map of the form II structure at a resolution of 2.65 Å. The 
electron density map is contoured at 1.0σ. The Cα traces of the Rv0302 molecules in the asymmetric 
unit are in orange and yellow. 
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Table 1.  Data collection, phasing and structural refinement statistics of Rv0302. 
Data set Rv0302 form I Ta6Br122+ 
derivative 
Rv0302 form II 
Data collection 
Wavelength (Å) 0.9792 1.2550 0.9792 
Space group P6122  P6122  P21212 
Cell constants (Å)    
a 116.6 117.7 46.1 
b 116.6 117.7 77.1 
c 94.1 93.7 118.6 
α, β, γ (°) 90,90,120 90,90,120 90,90,90 
Resolution (Å) 2.04 (2.11-2.04) 4.10 (4.25-4.10) 2.65 (2.74-2.65) 
Completeness (%) 99.8 (100) 91.4 (92.1) 97.3 (97.6) 
Total reflections 216,053 303,871 847,565 
Unique reflections 24,642 3,377 12,880 
Redundancy 7.6 (7.6) 3.1 (3.0) 4.5 (4.5) 
Rmerge (%) 4.3 (38.3)  13.0 (39.4) 10.5 (33.4) 
!I/σ(I)"  52.6 (4.9) 8.3 (3.7) 12.2 (3.7) 
Phasing 
Number of sites  2  
Resolution used (Å)  4.1  
Phasing power    
(acentric/centric)  0.81/0.55  
RCullis    
(acentric/centric)  0.88/0.84  
Figure of merit    
(acentric/centric)  0.34/0.19  
Refinement 
Rwork (%) 19.2  23.3 
Rfree (%) 21.5  26.8 
B-factors    
Overall(Å2) 55.2  49.5 
Ligands(Å2) 51.5   
Rms deviations    
Bond (Å) 1.336  0.576 
Angles (o) 0.013  0.002 
Ramachandran analysis 
Most favored (%) 97.8  98.0 
Allowed (%) 2.2    2.0 
Generously allowed (%) 0.0  0.0 
Disallowed (%) 0.0  0.0 
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Figure 3.  Structure of the M. tuberculosis Rv0302 regulator. (A) Ribbon diagram of a 
protomer of the form I structure of Rv0302. The molecule is colored using a rainbow gradient 
from the N!terminus (blue) to the C!terminus (red). (B) Ribbon diagram of the form I 
structure of the Rv0302 dimer. Each subunit of Rv0302 is labeled with a different color (red 
and yellow). The Figure was prepared using PyMOL (http://www.pymol.sourceforge.net). 
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Figure 4.  Structural comparison of forms I and II of the Rv0302 regulator. (A) This is a 
superimposition of the dimeric structures of forms I and II (green, form I; orange, form II). 
For clarity, only the right subunit of helices α1–α9 the form II structure (orange) are labeled. 
The arrow indicates a change in orientation of the right subunit of form I when compared with 
the structure of form II. (B) Side view of the superimposition of the dimeric structures of 
forms I and II (green, form I; orange, form II). For clarity, only the right subunit of helices 
α1–α9 of form II structure (orange) are labeled. This view depicts a 9° rigid body rotation of 
the right subunit (α1–α9) of form I with respect to that of form II. 
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Figure 5.  Electron density map and the isopropanol binding site. (A) Stereo view of the Fo–
Fc electron density map of the bound isopropanol in Rv0302. The bound isopropanol is shown 
as a stick model (green, carbon; blue, nitrogen). The Fo–Fc map is contoured at 3.0σ (blue 
mesh). (B) The iospropanol!binding site of Rv0302. Residues involved in isopropanol binding 
are in orange sticks. The bound isopropanol is shown as green sticks. Dotted lines depict the 
hydrogen bonds. 
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Regulator–ligand interactions 
Isothermal titration calorimetry  
Recently, we have found that the M. tuberculosis Rv3249c regulator is able to recognize 
palmitic acid, a saturated fatty acid containing 16 carbons with the molecular formula 
C16H32O2.44 Since both Rv0302 and Rv3249c were predicted to regulate the expression of 
the mmpS1/L1, mmpL3, mmpL7, and mmpL11 genes, it is possible that these two regulators share 
a similar set of ligands. Therefore, we decided to test if Rv0302 is capable of binding palmitic 
acid. Isothermal titration calorimetry (ITC) was then used to study the interaction between 
Rv0302 and this ligand. This titration depicts a typical hyperbolic binding curve, with 
thermodynamic parameters of −543.6'±'43.5 cal mol−1 (ΔH) and 21.0 cal mol−1  deg−1 (ΔS). The 
equilibrium dissociation constant (K D) for the binding of Rv0302 to palmitic acid was measured 
to be 10.5'±'2.3 µM (Fig.6). Indeed, our data indicate that Rv0302 is capable of recognizing this 
fatty acid.  
 
 
 
Figure 6. Representative ITC for the binding of 
palmitic acid to Rv0302. (A) Each peak corresponds 
to the injection of 10 µL of 500 µM palmitic acid in 
buffer containing 10 mM Na!phosphate (pH 7.2), 100 
mM NaCl, and 0.001% DDM into the reaction 
containing 14.5 µM Rv0302 dimer in the same buffer. 
(B) Cumulative heat of reaction is displayed as a 
function of the injection number. The solid line is the 
least!square fit to the experimental data, giving a KD 
of 10.5'±'2.3 µM. 
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Regulator–DNA interactions 
Fluorescence polarization assay 
Fluorescence polarization was used to quantify the strength of regulator–DNA 
interactions. To identify regulatory targets of these proteins, we used ChIP!Seq data from 
Galagan et al. and the TBDB.11,22,36 Regions of the M. tuberculosis H37Rv genome that were 
identified by these experiments to interact with Rv0302 were first examined to find potential 
binding sequences for each individual protein. Typically, TetR!family proteins interact with 
DNAs via symmetric palindromic stretches called inverted repeats (IRs), approximately 15–30 
nucleotides long. Thus, the search was narrowed to include sequences that contain these patterns. 
For Rv0302, we were able to identify a putative IR sequence located in one or more of the M. 
tuberculosis H37Rv genes encoding MmpL transporter proteins (Table 2). These DNA 
sequences are in good agreement with both the consensus binding sequences and protein–DNA 
interactions determined by others.37 In short, we have compiled additional evidence that the 
Rv0302 protein may act as a regulator for mmpL6 and mmpL11. 
Fluorescence polarization assays were then performed using the purified Rv0302 
regulator protein and duplex DNAs. We quantified the interaction of this regulator with the DNA 
sequences listed in Table 2. These DNA sequences are located within the operons 
of mmpL11 and mmpL6. In addition, we were able to locate an IR sequence within the promoter 
region of rv0302. The experiments suggest that Rv0302 binds these DNA sequences 
with KD values in the nanomolar range (Table 2 and Fig. 7). Interestingly, the fluorescence 
polarization data indicate that Rv0302 binds these DNA with a stoichiometry of one Rv0302 
dimer per DNA duplex. 
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Figure 7.  Representative fluorescence polarization of Rv0302. (A) The binding isotherm of 
Rv0302 with the 28!bp DNA located within the promoter region of mmpL11, showing a KD 
of 40.4'±'4.9 nM. (B) The binding isotherm of Rv0302 with the 29!bp DNA located within 
the promoter region of mmpL6, showing a KD of 58.5'±'2.9 nM. (C) The binding isotherm of 
Rv0302 with the 24!bp DNA located within the promoter region of rv0302, showing a KD of 
80.9'±'9.2 nM. Fluorescence polarization is defined by the equation, FP'='(V – H)/(V'+'H), 
where FP equals polarization, V equals the vertical component of the emitted light, and H 
equals the horizontal component of the emitted light of a fluorophore when excited by 
vertical plane polarized light. FP is a dimensionless entity and is not dependent on the 
intensity of the emitted light or on the concentration of the fluorophore. mP is related to FP, 
where 1 mP equals one thousandth of a FP. 
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Table 2. Affinity for DNA Binding by Rv0302 
 
a The IR sequence was underlined. 
b F denotes the fluorescein which was covalently attached to the 5′ end of the 
oligodeoxynucleotide (reversed) by a hexamethylene linker. 
 
 
 
Gel filtration 
To confirm the dimeric oligomerization of Rv0302 depicted by the crystal structures, we 
performed a gel filtration experiment using the purified Rv0302 protein. The result suggests an 
average molecular weight of 46.3'±'2.5 kDa. This value is in good agreement with the theoretical 
value of 48.4 kDa for two Rv0302 molecules, indicating that the Rv0302 regulator is dimeric in 
solution. 
 
DNA sequence Location KD (nM) 
Hill 
coefficient(n) 
5′!GCCTGCGCCGCGTCGTCGCGGTGCCTGT!3′a  
5′!F!ACAGGCACCGCGACGACGCGGCGCAGGC!3′b 
mmpL11 12.6'±'1.7 1.2.'±'0.2 
5′!TGCCCGGGGCGCGACCACGCCCCGTACCT!3′ 
5′!F!AGGTACGGGGCGTGGTCGCGCCCCGGGCA!3′ 
mmpL6 19.1'±'5.2 1.1'±'0.1 
5′!TTTCTTGGCGGGAACGCCCACTGG!3′ 
5′!F!CCAGTGGGCGTTCCCGCCAAGAAA!3′ 
rv0302 13.7'±'2.8 1.1'±'0.1 
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Our fluorescence polarization experiments suggest that the Rv0302 protein uses a simple 
binding stoichiometry with a 1:1 dimeric Rv0302!to!duplex DNA molar ratio to interact with the 
DNA sequences located within the operons of mmpL11, mmpL6, and rv0302, respectively. To 
confirm this protein–DNA binding stoichiometry, gel filtration experiment was carried out using 
the purified Rv0302 protein pre-incubated with the purified, complementary, annealed 
oligonucleotides that contain the sequences within the operons of mmpL11, mmpL6, and rv0302, 
individually. The results suggest average molecular weights of 65.5'±'3.1, 70.7'±'4.6 and 
58.9'±'4.5 kDa for these Rv0302–DNA complexes (Fig. 8). These values are in good agreement 
with the corresponding theoretical values of 65.8, 66.4 and 63.3 kDa for two Rv3066 molecules 
bound to the respective DNAs, confirming the stoichiometry of these Rv0302!DNA bindings is 
1:1 dimeric Rv0302!to!DNA molar ratio.  
 
Figure 8. Representative gel filtration 
experiment. The experiment demonstrated that 
Rv0302 is dimeric in solution. In addition, one 
Rv0302 dimer is found to bind one duplex DNA. 
The y!axis values were defined as: 
Kav'='(Ve'−'V0)/(VT'−'V0), where VT, Ve, and V0 are 
the total column volume, elution volume, and 
void volume of the column, respectively. 
Standards used were: A, cytochrome C (Mr 
12,400); B, carbonic anhydrase (Mr 29,000); C, 
albumin bovine serum (Mr 66,000); D, alcohol 
dehydrogenase (Mr 150,000); and E, β!amylase 
(Mr 200,000). The void volume was measured 
using blue dextran (Mr 2,000,000). Samples for 
the measurements were: red triangle, Rv0302; 
green diamond, Rv0302!mmpL11; orange 
inverted triangle, Rv0302!mmpL6; blue square, 
Rv0302!rv0302. 
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Electrophoretic mobility shift assay 
ChIP!Seq data suggests that Rv0302 regulates expression of rv0302, mmpS2/L2, 
and mmpL11 [Fig. 9(A)]. We performed EMSAs using purified Rv0302 to demonstrate direct 
transcriptional regulation by Rv0302. We observed a concentration!dependent shift of 
the rv0302, mmpL2, and mmpL11 probes [Fig. 9(B–D)]. As a negative control, we used a DNA 
probe that has no predicted binding sites for Rv0302. EMSAs were also performed in the 
presence of nonlabeled “cold” probe. Release of Dig!labeled probe was observed consistent with 
specific binding of Rv0302 to the mmpL11 probe [Fig. 9(C)]. As fluorescence polarization study 
suggested that Rv0302 binds palmitic acid, we performed an EMSA in the presence and absence 
of palmitic acid to demonstrate this experimentally. Indeed, addition of palmitate reduced 
binding of Rv0302 to the rv0302 probe [Fig. 8(D)]. 
 
 
Conclusion 
In this article, we describe the crystal structures of the Rv0302 transcriptional regulator, 
which contribute to the regulatory network that controls the expression levels of the MmpL 
transporters. Specifically, the Rv0302 protein should regulate the genes mmpL1, mmpL2, mmpL3, 
mmpL6, mmpL7, mmpL9, and mmpL11. MmpL transporters significantly contribute to the export 
of important lipid components of the mycobacterial cell wall and are necessary for the virulence 
of this pathogen. Our experimental data demonstrate a direct binding of this transcriptional 
regulator to intragenic and promoter DNAs, providing evidence for the transcriptional control 
of mmpL gene expression. Multiple transcriptional factor binding sites exist within the promoter  
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Figure 9. Rv0302 binds to promoter regions of mmpL11 and rv0302 and intragenic region of 
mmpL2. (A) A schematic depicting the DNA probes used in EMSAs. (B) EMSAs were performed 
6 nM Dig!labeled probe and the indicated micromolar concentrations of protein. (C) To 
demonstrate specificity, the MmpL11 EMSA was performed in the presence of nonlabeled 
(“cold”) probe. Reactions were performed with 6 nM Dig!labeled probe, the indicated micromolar 
concentrations of protein, and 360 nM cold probe. (D) Ligand!bound Rv0302 does not bind target 
probes. EMSA was performed using 12 nM Dig!labeled probe and 0.1 µM Rv0302 in the absence 
or presence of the indicated concentration of palmitic acid. An arrow denotes the shifted probes 
and the asterisk notes the accumulation of free Dig!labeled probe. 
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and intragenic region of the mmpL genes, and each transcriptional regulator recognizes 
several mmpL regulatory regions. For example, both Rv0302 and Rv3249c are able to bind to 
different regulatory sequences within the mmpL11 gene. Indeed, our experimental data indicate 
that these two regulators may also share the same palmitate ligand. These findings suggest 
that mmpL gene expression may rely on a complex interplay of multiple transcription regulators. 
Further experiment is needed to confirm this observation. 
The TetR family of regulators uses a few distinct mechanisms for modulating 
transcriptional regulation. However, the net consequence of binding of inducing ligands to these 
regulators is essentially the same. Ligand binding at the C!terminal regulatory domain triggers a 
long distance conformational change at the N!terminal DNA binding domain, resulting in the 
release of the regulator from its operator DNA. The TetR!family regulators use the N!terminal 
recognition helix α3 to bind the major groove of B!DNA. The two crystal structures of Rv0302 
have allowed us to understand how this regulator controls gene expression. It appears that ligand 
binding may trigger a rotational motion of one subunit of Rv0302 in relation to the next subunit 
within the dimer. This rotational motion presumably makes the relative orientation of the two N!
terminal DNA!binding domains of the regulator incompatible with the two consecutive major 
grooves of the operator B!DNA. Similar rigid body rotational movement has been found in the 
SimR and Rv3066 regulators, where rigid body rotation within subunits of the dimer in relation 
to each other contributes to the induction process.34,38 The net result is that this dimeric Rv0302 
regulator is released from the promoter, which in turn initiates the expression of the mmpL genes.  
 
 
36 
 
Materials and methods 
Cloning of rv0302 
The rv0302 ORF from genomic DNA of M. tuberculosis strain H37Rv was amplified by 
polymerase chain reaction (PCR) using the primers 5′!CTTTAAGAA 
GGAGATATACCATGGTGGGCGTTCCCGCCAAGAAAAAAC!3′ and 5′! 
GATCCTCAGTGATGATGGTGGTGATGTGTCTCCTCCAGGAGGACGGGAATC!3′. The 
corresponding PCR product was digested with NcoI and BamHI, extracted from the agarose gel 
and inserted into pET15b as described by the manufacturer (Merck, Kenilworth, NJ). The 
recombinant plasmid, pET15bΩrv1219c, was transformed into DH10b cells, and the 
transformants were selected on Luria Broth (LB) agar plates containing 100 µg/mL ampicillin. 
The presence of the correct rv1219csequence in the plasmid construct was verified by DNA 
sequencing. 
 
Expression and purification of Rv0302 
Briefly, the full!length protein Rv0302 containing a 6×His tag at the C!terminus was 
overproduced in E. coli BL21(DE3) cells possessing pET15bΩrv0302. Cells were grown in 6 L 
of LB medium with 100 µg/mL ampicillin at 37°C. When the OD600 reached 0.5, the culture was 
treated with 0.2 mM IPTG to induce Rv0302 expression, and cells were harvested within 3 h. 
The collected bacterial cells were suspended in 100 mL ice!cold buffer containing 20 mM Na!
HEPES (pH 7.2) and 250 mM NaCl. The cells were then lysed with a French pressure cell. Cell 
debris was removed by centrifugation for 45 min at 4°C and 20,000 rev/min. The crude lysate 
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was filtered through a 0.2 µm membrane and loaded onto a 5 mL Hi!Trap Ni2+!chelating column 
(GE Healthcare Biosciences, Pittsburgh, PA) pre!equilibrated with 20 mM Na!HEPES (pH 7.2) 
and 250 mM NaCl. To remove unbound proteins and impurities, the column was first washed 
with eight column volumes of buffer containing 20 mM imidazole, 250 mM NaCl, and 20 
mM Na!HEPES (pH 7.2), and then five column volumes of buffer containing 50 mM imidazole, 
250 mM NaCl, and 20 mM Na!HEPES (pH 7.2). The Rv0302 protein was then eluted with three 
column volumes of buffer containing 300 mM imidazole, 250 mM NaCl, and 20 mM Na!HEPES 
(pH 7.2). The purity of the protein was judged using 12.5% SDS!PAGE stained with Coomassie 
Brilliant Blue. The purified protein was extensively dialyzed against buffer containing 100 
mM imidazole, 150 mM NaCl, and 20 mM Na!HEPES (pH 7.5) and concentrated to 20 mg/mL. 
 
Crystallization of Rv0302  
All crystals of the 6×His Rv0302 regulator were obtained using hanging drop vapor 
diffusion. The form I Rv0302 crystals were grown at room temperature in 24!well plates with the 
following procedures. A 1 µL protein solution containing 20 mg/mL Rv0302 protein in 20 
mM Na!HEPES (pH 7.5), 150 mM NaCl, and 100 mM imidazole was mixed with 1 µL of 
reservoir solution containing 30% polyethylene glycol (PEG) 400, 0.1M Na!HEPES (pH 7.5), 
0.2M NaCl, and 10% isopropanol, with an addition of 2% benzamidine·HCl. The resultant 
mixture was equilibrated against 500 µL of the reservoir solution. Crystals appeared overnight 
and grew to a full size in the drops within 2 weeks. Typically, the dimensions of the crystals 
were 0.1 mm × 0.3 mm × 0.3 mm. Further cryoprotection was not necessary. 
38 
 
Crystals of the tantalum derivative were prepared by incubating the form I crystals 
overnight in a solution containing 30% PEG 400, 0.1M Na!HEPES (pH 7.5), 0.2M NaCl, 10% 
isopropanol, 2% benzamidine·HCl, and 1 mM (Ta6Br12)2+·2Br− (Jena Bioscience, Jena, 
Germany). 
The form II Rv0302 crystals were grown at room temperature in 24!well plates by mixing 1 µL 
of protein solution with 1 µL of reservoir solution containing 18% PEG 2000, 0.1M K!MES (pH 
6.5), 0.2M NaCl, and 10% isopropanol. The resultant mixture was equilibrated against 500 µL of 
the reservoir solution. Crystals appeared overnight and grew to a full size in the drops within 1 
week. Typically, the crystals were plate!like with dimensions 0.2 mm × 0.2 mm × 0.05 mm. 
Cryoprotection was achieved by raising the PEG 2000 concentration stepwise to 25%. 
 
Data collection, structural determination, and refinement 
All diffraction data were collected at 100K at beamline 24ID!C located at the Advanced 
Photon Source, using a Pilatus 6M detector (Dectris, Switzerland). Diffraction data were 
processed using DENZO and scaled using SCALEPACK.45 The form I crystals of Rv0302 
belong to the space group P6122 (Table 1). Based on the molecular weight of Rv0302 (23.8 kDa), 
the asymmetric unit is expected to contain one regulator molecule with a solvent content of 
68.7%. Two tantalum cluster sites were identified using SHELXC and SHELXD46 as 
implemented in the HKL2MAP package.47 Single isomorphous replacement with anomalous 
scattering was used to obtain experimental phases using the program MLPHARE.48,49 The 
resulting phases were then subjected to density modification using the program PARROT.50 The 
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phases were of excellent quality and allowed for tracing of most of the molecule in PHENIX 
AutoBuild,51 which led to an initial model with over 90% amino acid residues containing side 
chains. The remaining part of the model was manually constructed using the program 
Coot.52 Then, the model was refined using PHENIX51 leaving 5% of reflections in Free!R set. 
Iterations of refinement using PHENIX51 and CNS53 and model building in Coot52 lead to the 
current model with excellent geometrical characteristics (Table 1). 
The form II crystal took the space group P212121. This structure was determined by 
molecular replacement, using the form I structure as the search model. The program 
PHASER54 was used to carry out the MR calculations. Structural refinements were then 
performed using PHENIX51 and CNS53 (Table 1). 
 
Isothermal titration calorimetry 
We used ITC to determine the binding affinity of palmitic acid to the purified Rv0302 
regulator. Measurements were performed on a VP!Microcalorimeter (MicroCal, Northampton, 
MA) at 25°C. Before titration, the protein was thoroughly dialyzed against buffer containing 
10 mM Na!phosphate pH 7.2, 100 mM NaCl, and 0.001% n!dodecyl!β!D!maltoside (DDM). The 
protein concentration was determined using the Bradford assay and then adjusted to a dimeric 
concentration of 14.5 µM. The ligand solution containing 500 µM palmitic acid, 10 mM Na!
phosphate pH 7.2, 100 mM NaCl, and 0.001% DDM was used as the titrant. Binding experiments 
were carried out with the protein solution (1.4 mL) in the cell and the ligand solution as the 
injectant. Thirty injections of 10 µL each of the ligand solution were used for data collection. 
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Injections occurred at intervals of 240 s, and the duration time of each injection was 20 s. 
Heat transfer (µcal/s) was measured as a function of elapsed time (s). The mean enthalpies 
measured from injection of the ligand in the buffer were subtracted from raw titration data before 
data analysis with ORIGIN software (MicroCal, Westborough, MA). Titration curves were fitted 
by a nonlinear least squares method to a function for the binding of a ligand to a macromolecule. 
Nonlinear regression fitting to the binding isotherm provided us with the equilibrium binding 
constant (K A'='1/K D) and enthalpy of binding (ΔH). Based on the values of K A, the change in 
free energy (ΔG) and entropy (ΔS) were calculated with the 
equation: ΔG'='−RT ln K A'='ΔH'−'TΔS, where T is 273 K and R is 1.9872 cal/K per mol. 
Calorimetry trials were also carried out in the absence of Rv0302 in the same experimental 
conditions. No change in heat was observed in the injections throughout the experiment. 
 
Fluorescence polarization assay 
Fluorescence polarization assays were used to determine the affinity for DNA binding by 
Rv0302. All oligodeoxynucleotides and fluorescein!labeled oligodeoxynucleotides were 
purchased from Integrated DNA Technologies (Coralville, IA). The sequences of these 
oligodeoxynucleotides are summarized in Table 2. The fluoresceinated ds!DNAs were prepared 
by annealing the oligodeoxynucleotide and its corresponding fluorescein!labeled 
oligodeoxynucleotide together. Fluorescence polarization experiment was done using a DNA 
binding solution containing 10 mM Na!phosphate (pH 7.2), 100 mM NaCl, 2.5 nM 
fluoresceinated DNA, and 1 µg of poly(dI!dC) as nonspecific DNA. The protein solution 
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containing 500 nM dimeric Rv0302 and 2.5 nM fluoresceinated DNA was titrated into the DNA 
binding solution until the millipolarization (mP) become unchanged. All measurements were 
performed at 25°C using a PerkinElmer LS55 spectrofluorometer equipped with a Hamamatsu 
R928 photomultiplier. The excitation wavelength was 490 nm, and the fluorescence polarization 
signal (in ΔP) was measured at 525 nm. Each titration point recorded was an average of 15 
measurements. 
Data were analyzed using the equation, P'='{(P bound'− Pfree)[protein]/(K D'+'[protein])}'+'P free, 
where P is the polarization measured at a given total protein concentration, P free is the initial 
polarization of free fluorescein!labeled DNA, P bound is the maximum polarization of specifically 
bound DNA, and [protein] is the protein concentration. The titration experiments were repeated 
three times to obtain the average KD value. Curve fitting was accomplished using the program 
ORIGIN (OriginLab, Northampton, MA). 
Gel filtration 
A protein liquid chromatography Superdex 200 16/60 column (GE Healthcare 
Biosciences, Pittsburgh, PA) with a mobile phase containing 20 mM Na!phosphate (pH 7.2) and 
100 mM NaCl was used in the gel filtration experiments. Blue dextran (Sigma!Aldrich, St. Louis, 
MO) was used to determine the column void volume, and proteins for use as gel filtration 
molecular weight standards were cytochrome C (M r12,400), carbonic anhydrase (M r 29,000), 
albumin bovine serum (M r 66,000), alcohol dehydrogenase (M r150,000), and β!Amylase 
(M r 200,000). All these standards were purchased from Sigma!Aldrich (St. Louis, MO). The 
molecular weights of the experimental samples were determined following the protocols 
supplied by the manufacturers. 
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Electrophoretic mobility shift assay 
Probes were amplified from the H37Rv genome using the primers listed in Table 3. All 
probes were labeled with Digoxigenin using the Roche DIG Gel Shift kit. For EMSA analysis, 
12 nM Dig!labeled probe and the indicated micromolar concentrations of protein were incubated 
for 45 min at room temperature in the Roche binding buffer modified by the addition of 0.25 
mg/mL herring sperm DNA, and 0.75 mg/mL poly(d[I!C]). For ligand competition assays, the 
stock solution of palmitic acid was made in dimethyl sulfoxide (DMSO) and a solvent control 
reaction included at the highest concentration of DMSO. All reactions were resolved on a 6% 
native polyacrylamide gel in TBE buffer, transferred to nylon membrane and Dig!labeled DNA–
protein complexes detected following the manufacturer's recommendations. Chemiluminescent 
signals were acquired using an ImageQuant LAS 4000 (GE). 
 
Table 3. Primers used to Amplify EMSA Probes 
Primer Sequence 
Rv0302F.0302 5′!CGGTACTGCACGTCGACAA!3′ 
Rv0302R.0302 5′!GTTCGGTCGCGTCGAGAATC!3′ 
mmpL11F.0302 5′!CCGAGATGGCAGGATGACGG!3′ 
mmpL11R.0302 5′!TCGCTGATGGTTCGGCCAG!3′ 
mmpL2F.0302 5′!TTATCTGGCATGGCACGCTT!3′ 
mmpL2R.0302 5′!TTGCCGTCCGGAGACAAAAA!3′ 
 
Protein data bank accession code 
Coordinates and structural factors for the structures of Rv0302 have been deposited in the 
RCSB Protein Data Bank with accession codes 5D18 and 5D19 for the form I and form II 
conformations, respectively. 
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CHAPTER III 
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Introduction 
 
Carbon dioxide (CO2) is an essential substrate for photosynthesis, which provides the 
basis for the synthesis of organic compounds and nutrients. Without CO2, the life of 
photosynthetic organisms and even animals would not be possible. However, the central 
enzyme of photosynthetic CO2 assimilation, rubilose-1,5-bisphosphate carboxylase 
oxygenase (Rubisco)1,2,3, which is probably the most abundant enzyme on earth, has a low 
affinity for CO2 and slow catalytic turnover rate for carboxylation4,5. As a result, the 
efficiency of this photosynthetic process is strongly dependent upon the concentration of CO2 
in the vicinity of Rubisco. Given the fact that the diffusion rate of Ci in water is 104 times 
slower than that in air, aquatic photosynthetic species appear to endure even more obstacles 
in terms of scavenging inorganic carbon (Ci) resources. To overcome this hurdle, microalgae 
and cyanobacteria have developed a CO2-concentrating mechanism (CCM)6,7,8,9, which is 
one of the most effective strategies for CO2 enrichment. These CCMs utilize diverse and 
active Ci uptake systems capable of accumulating intracellular Ci concentration up to 1,000-
fold from low CO2 environments. As microalgae and cyanobacteria contribute significantly 
to global CO2 sequestration and have shown enormous potential as an alternative future 
energy source, enhanced knowledge of CCM will offer us guidance to boost biomass 
production and improve the efficiency of photosynthetic carbon fixation in crop species that 
lack a CCM. 
 In comparison with cyanobacterial CCMs, the CCMs of eukaryotic microalgae are 
more complex mainly due to the involvement of a larger number of intracellular 
compartments. The green alga Chlamydomonas reinhardtii has served as a model organism 
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for decades10, allowing us to identify key components that are involved in CO2 and 
bicarbonate (HCO3-) uptake of the CCM. However, a complete picture of the CCM remains 
unclear. In most natural environments, CO2 and HCO3- are the two major sources of Ci for C. 
reinhardtii assimilation. As the Ci concentration, pH and temperature vary, the availability of 
both the Ci species also changes. This change may activate and induce the expression of 
various Ci transport proteins to accommodate intracellular Ci uptake. At least three 
acclimation states have been identified in C. reinhardtii based on physiological responses to 
various CO2 concentrations. These concentrations are high CO2 (0.5-5%), low CO2 (0.03-
0.4%) and very low CO2 (<0.02%)7.                   
 To better understand how the CCM works, it is important to elucidate the structure 
and function of Ci transport proteins participating in Ci enrichment. In C. reinhardtii, Ci 
uptake occurs at the plasma membrane, chloroplast envelope and inside the chloroplasts. 
Many of these CO2-responsive genes encode putative Ci transporters and CO2 uptake 
systems. These membrane proteins include LCI1 (low CO2 inducible gene 1)11 and HLA3 
(high light activated 3, also known as MRP1)12 found in the plasma membrane, as well as 
LCIA (low CO2 inducible gene A, also known as NAR1.2)13 located at the chloroplast 
envelope. 
! Several Ci transporters functionally confirmed in cyanobacteria and algae, including 
BCT1,14,15 BicA16,17
 
and SbtA17,18
 
in cyanobacteria and HLA319-21
 
and LCIA21,22
 
in C. 
reinhardtii, belong to well-characterized transporter families (BCT1 and HLA3 to the ATP 
binding cassette (ABC) transporter family, BicA to the sulphate transporter (SulP) family, 
and LCIA to the Formate-Nitrite Transporter (FNT) family). Although diversified by their 
molecular identities, energization modes, substrate affinity and Ci-dependent expression 
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patterns, these Ci transporters exclusively belong to typical energy-dependent, integral 
membrane proteins like other nutrient transporters. Therefore, the biochemical basis for their 
HCO3-
 
uptake is similar to the process catalyzed by carrier-mediated transport, which is well 
characterized in many prokaryotic and eukaryotic organisms. However, LCI1 appears to 
represent a completely novel type of transporter.  
LCI1 is encoded by nuclear DNA, translated in the cytoplasm, and localized in the 
plasma membrane, where it is involved in Ci transport and accumulation.23 LCI1 was 
predicted to possesses four hydrophobic domains, but the first domain at the N-terminal end 
was presumed to serve as a signaling peptide.23 To elucidate the structural basis of the 
mechanisms for Ci enrichment, we here report a crystal structure of the full-length LCI1 
membrane protein, which is consistent with LCI1 being able to catalyze the transport of CO2
 
across the plasma membrane.  
    
 
Results and discussion 
 
The crystal structure of LCI1 was determined to a resolution of 3.2 Å using single 
isomorphous replacement (Fig. 1, Fig. S1 and Table S1). Three LCI1 molecules, which form 
a homotrimer, were found in the asymmetric unit. Superimposition of these three protomers 
gives RMSDs between 0.39 and 0.41 Å (over 165 C# atoms), suggesting that their 
conformations are nearly identical to each other. The composition of LCI1 is predominantly 
hydrophobic, with most of the amino acids embedded in the transmembrane. Apparently, 
LCI1 does not contain any signaling peptide. Thus, the N- and C-terminal ends of this protein 
55 
 
are located at the cytoplasm. Each LCI1 protomer comprises four helical transmembrane 
segments (TMs) and two extra-membrane #-helices (#s), which are located right above the 
plasma membrane surface. The TMs and #s are designated numerically from the N- to C-
termini: TM1 (6-38), #1 (47-62), TM2 (73-95), TM3 (108-133), #2 (136-141) and TM4 
(144-169). Of the four TMs, TM1 is relatively long and part of this helix (residues 34-38) is 
exposed to solvent. In addition to this top portion of TM1, helices #1 and #2 make up a 
small periplasmic domain of the membrane protein. The LCI1 trimer orients in a way that its 
pseudo threefold axis is perpendicular to the membrane surface. This threefold axis is 
surrounded by the three closely packed TM3 helices, which seal the central trimer interface 
against the passage of substrates.    
  
In a view parallel to the membrane plane, the LCI1 trimer is about 60 Å tall, 40 Å 
wide and 40 Å thick. A bundle of four antiparallel helices constitute an LCI1 subunit and it 
folds into a cylindrical structural feature within the transmembrane region. Based on the 
crystal structure, it is likely that each protomer forms a pathway for transport or conductance. 
Indeed, the bundle of four antiparallel helices of each LCI1 molecule contributes to create a 
tunnel that spans approximately two-thirds of the transmembrane (Fig. 2). Interestingly, the 
two short #1 and #2 helices, which are exposed to solvent in the periplasm, form the 
entrance of this channel. In particular, residues L42, Y52, V55, T137 and V141 are found to 
encircle this entrance. The tunnel is hydrophobic in nature. Nineteen aromatic and 
hydrophobic residues, including V26, A30, L33, L42, Y52, Y56, F60, I66, F77, I83, I84, 
A128, V141, F142, I147, A150, L154 and V157, participate to construct this tunnel. The 
locations of these hydrophobic residues suggest that they may be important to forming a path 
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for substrate transport. In addition, the three polar residues Q80, N125 and T137 are also 
involved in lining the wall of the tunnel.  
Apparently, the structure captures a closed conformation of the LCI1 channel. A 
negatively charged residue E87 is found within the transmembrane region of LCI1. The side 
chain of this residue likely makes a hydrogen bond with the side chain of N161 to form a 
gate and blocks this transmembrane tunnel (Fig. 2). Interestingly, the interior surface of this 
LCI1 channel is strikingly electronegative (Fig. 3), suggesting that this channel may tend to 
transport neutral or positively charged substrates. Thus, LCI1 may be in favor of CO2 rather 
than HCO3- and facilitate the passage of this neutral molecule through the plasma membrane. 
Surprisingly, an extra electron density was found right below this gate and towards 
the cytoplasmic side of the elongated tunnel of each subunit of the LCI1 protein, indicating 
the existence of a fortuitous bound ligand co-purified and co-crystallized with this membrane 
protein. The shape of this extra density is compatible with a CO2 molecule (Fig. 4). Within 
4.5 Å of the bound ligand, it was found that there are at least five amino acids, including T19, 
T94, F91, I115 and T164, involved in the binding. Ab initio calculations have suggested that 
these amino acids have a strong affinity for CO215,16, posing an idea that the fortuitous ligand 
may be CO2. 
We then used AutoDock Vina17 to search for potential CO2-binding sites within the 
LCI1 channel protein. AutoDock Vina could only find one potential CO2-binding site located 
within the bundle of four antiparallel helices of the membrane protein. Interestingly, this site 
coincides with the extra electron density (Fig. 4), suggesting that LCI1 may be capable of 
binding CO2.     
57 
 
To confirm the trimeric architecture of LCI1, we turned to use non-denaturing mass 
spectrometry (native MS) to elucidate the oligomerization state of this membrane protein in 
aqueous phase. This approach should allow us to obtain valuable information regarding the 
sample mass, oligomerization state and subunit stoichiometry. In addition, it should lead us 
to identify bound lipid molecules if they are in complex with the membrane protein. The 
spectra showed a well-resolved charge state series that correspond to the trimeric 
oligomerization of LCI1. Additionally, native MS revealed the presence of bound lipids co-
purified with this protein (Fig. 5). Using lipidomic approach, we identified that these bound 
lipids are phosphatidic acid (16:0/18:1) (PA(16:0/18:1)) and phosphatidic acid(18:1/18:1) 
(PA(18:1/18:1)). These lipids are bound within the purified LCI1 protein in different 
combinations. The observed masses of these lipid-LCI1 complexes are listed in Table S2.    
To elucidate if LCI1 is capable of transporting CO2 across the membrane, we 
performed steered molecular dynamics (SMD) simulations on this protein embedded in 
palmitoyloleoylphosphatidylethanolamine (POPE) membrane bilayer. We measured the 
magnitude of applied forces necessary to maintain a constant velocity of the CO2 molecule 
moving through the channel created by the LCI1 protomer. We initially pushed CO2 into the 
LCI1 channel via the opening created by the #1 and #2 helices. SMD suggests that CO2 can 
migrate smoothly into the channel. The force applied to maintain a constant velocity of CO2 
migration is shown in Fig. 6. Interestingly, as CO2 reaches the vicinity of the CO2-binding 
site identified by the crystal structure, a noticeable reduction in the applied force is observed. 
The calculation suggests that residues lining the wall of this region may have the capacity to 
push CO2 further into the channel, allowing the CO2 molecule to continue to propagate 
farther down the channel and then exit to the cytoplasm. 
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We also performed SMD simulations by applying a reversed force to push CO2 into 
the channel from the cytoplasmic side. The simulations indicate that the CO2 molecule can 
only migrate a short distance into the channel. As it arrives the CO2-binding site, we 
observed a significant conformational change between the transmembrane helices TMs 1 and 
2 of LCI1. These two helices seemingly perform a scissor-like motion and push CO2 back 
into the cytosol, suggesting that this channel is unidirectional.  
Similar SMD simulations were performed to investigate the possibility of HCO3- 
permeation through the channel. SMD simulations reveal that HCO3- can migrate from the 
periplasmic to cytoplasmic sides of LCI1 using a similar pathway. However, the forces 
involved to push the HCO3- ion through this channel are at least five times higher, suggesting 
that LCI1 is more favorable to CO2 passage (Fig. 6). These data are in good agreement with 
the electronegative nature of the LCI1 channel, which may not tolerate negatively charged 
ions. Like the CO2 simulations, SMD calculations suggest that HCO3- can only migrate a 
short distance when a reverse force was applied to push this ion from the cytoplasmic side 
into the LCI1 channel. 
The crystal structure of LCI1 suggests a substrate translocation mechanism, in which 
each LCI1 molecule within the trimer forms a channel for transport. Based on our structural 
model, we hypothesize that the reversible conversion of CO2 and HCO3- is a necessary 
prerequisite for importing Ci into the cytoplasm through this channel. This conversion 
process is driven by the electronegativity of local protein environments. The exterior surface 
of the small periplasmic domain of LCI1 does not seem to form extensive positively or 
negatively charged patches, suggesting that both CO2 and HCO3- are popular Ci species at 
this region. However, the entrance of each channel is surrounded with residues Y52, V55, 
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T137 and V141, which are more favorable for the passage of CO2 molecules.  Thus, we 
expect that CO2 is a more preferred Ci species than HCO3
- to enter the LCI1 channel from 
the periplasm (Fig. 7). Within the LCI1 channel, the interior surface is electronegative. This 
suggests that CO2 should be the predominant Ci species inside the channel and LCI1 should 
primarily translocate CO2 across the plasma membrane. At the cytoplasmic face of LCI1, it is 
found that its outermost surface, facing the cytoplasm, is highly electropositive. This local 
environment makes it more favorable for the negatively charged HCO3-
 
ions. Thus, the last 
step for Ci translocation through LCI1 is that CO2 must convert to HCO3
- before releasing to 
the cytoplasm. Since LCI1 itself has no recognizable carbonic anhydrase active site in this 
region, or elsewhere, this apparent need for hydration of transported CO2 to HCO3
- suggests a 
close interaction of LCI1 with a carbonic anhydrase at the cytoplasmic surface. LCI1, 
therefore, apparently operates via a transport mechanism unlike those of other Ci transporters 
functionally confirmed as HCO3-
 
transporters in cyanobacteria and algae, and unlike any 
previously described Ci transporter. It is a unique protein that transports Ci via a completely 
novel mechanism.
  


Figure 1. Structure of the Chlamydomonas reinhardtii LCI1. (a) Ribbon diagram of a monomer of LCI1 viewed in the 
membrane plane. The molecule is colored using a rainbow gradient from the N-terminus (blue) to the C-terminus (red). 
(b) Ribbon diagram of a trimer of LCI1 viewed in the membrane plane. The three protomers are colored green, red and 
yellow, respectively. The transmembrane segments (TMs) and !-helices (!s) of the front protomer (green) of LCI1 are 
labeled. The Figure was prepared using PyMOL (http://www.pymol.sourceforge.net). 
 
60 
  

Figure 2. Channel of LCI1. (a) Each subunit of LCI1 forms a channel (colored green) spanning approximately two-thirds of 
the transmembrane. This channel was calculated using the program HOLE27. The channel is closed by an interaction between 
the side chains of residues E87 and N161. (b) The channel (colored pink) of LCI1 is surrounded with 22 amino acids, 
including V26, A30, L33, L42, Y52, Y56, F60, I66, F77, Q80, I83, I84, N125, A128, T137, V141, F142, I147, A150, L154 
and V157. The potential CO2- binding site is located right below residues E87 and N161. This channel was calculated using 
the program CAVER (http://loschmidt.chemi.muni.cz/caver). The secondary structural elements of the LCI1 protomer are in 
gray. Residues that are involved in forming this channel are in green sticks. E87 and N161 are also included in the figure. 
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Figure 3. Electrostatic surface potentials of LCI1. Surface representations of the (a) inside, (b) top view and (c) bottom view 
of the LCI1 channel colored by charge (red; negative -15 kT/e, blue; positive +15 kT/e). 
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
Figure 4. Carbon dioxide binding site. (a) Stereo view of the Fc – Fc electron density map of bound CO2 in LCI1. The bound CO2 
molecule is shown as a stick model (cyan, carbon; blue, nitrogen). The Fo – Fc map is contoured at 3.0 σ (blue mesh). Residues 
involved in CO2 binding are in green sticks. The bound CO2 ligand is shown as green sticks. (b) This is a composite figure 
showing the locations of the predicted bound CO2 ligand (yellow) and bound CO2 (cyan) found in the crystal structure of LCI1. 
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Figure 5. Mass spectrum of LCI1 obtained under native conditions. The spectra indicate the presence 
of the LCI1 trimer (purple circles) and its charge state series. The measured mass of this trimer is 
66113.01 ± 0.27 Da, which is in good agreement with the theoretical mass of the trimeric LCI1 
protein (66115.8 Da) without the first methionine residue on each monomer. The other species (cyan, 
yellow and red triangles) correspond to the lipid bound trimers and these are endogenously purified. 
Lipid analysis on this sample revealed the presence of PA(16:0/18:1) and PA(18:1/18:1) as shown in 
Fig. S2. These lipids are bound in different numbers and combinations. All of the molecular masses 
observed are listed in Table 2. 
 
  

Figure 6. Steered molecular dynamics (SMD) simulations of the migration of CO2 and HCO3
- through LCI1. (a) The trajectory of CO2 through 
LCI1 in SMD is shown as blue mesh. LCI1 is oriented with the channel along the z-axis and the position of ligand along the channel is 
measured as distance from center of mass the protein along the z-axis. (b) Plots of applied forces as a function of ligand positions along the 
channel (blue, CO2; red, HCO3-). The plots indicate that pushing of HCO3- through the channel requires much larger force, suggesting that CO2 
may be the preferred ligand. The region corresponds to the observed CO2-binding site is highlighted by a black rectangle. The two peaks 
showing in the CO2 plot (blue) indicate local electrostatic interactions between (d) bound and residues E87 and N161; and (e) bound CO2 and 
residue Q16. (f) Root mean square fluctuations (RMSF) of the LCI1 residues during the SMD simulations with CO2 (blue) and HCO3- (red). 
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Figure 7. Proposed CO2 transport across the plasma membrane via LCI1. The LCI1 trimer is represented by a green envelope 
showing in the cartoon. The channel formed within a monomer of LCI1 is colored red. 
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Methods 
 
Cloning, expression and purification of C. reinhardtii LCI1  
Briefly, the full-length LCI1 membrane protein containing a 6xHis tag and a GFP tag 
at the C-terminus was overproduced in Pichia pastoris SMD1168H cells possessing the 
pPICZαΩLCI1 expression vector. Cells were grown at 29oC in 2 l of fermentation basal salts 
medium containing 26.7 ml/l 85%-phosphoric acid, 18.2 g/l K2SO4, 0.93 g/l CaSO4, 18.2 g/l 
K2SO4, 14.9 g/l MgSO4·7H2O, 4.13 g/l KCl, 20 g/l glycerol and 4.4 ml/l PTM1 trace salts 
(6.0 g/l CuSO4·5 H2O, 0.08 g/l NaI, 3.0 g/l MgSO4· H2O, 0.2 g/l Na2MoO4·2H2O, 0.02 g/l 
H3BO3, 0.5 g/l CoCl2, 20.0 g/l ZnCl2, zinc chloride, 65.0 g/l FeSO4·7H2O, 0.2 g/l biotin, 5.0 
ml/l H2SO4) (Invitrogen). The fermentation batch was bubbled with pure oxygen with a rate 
of 2 l/min. Temperature and pH were automatically maintained at 29 oC and 5.0, respectively, 
by water-cooling and the addition of 30% NH4OH solution. Glycerol fed-batch process was 
then initiated when the glycerol concentration was dropped to zero. 50% glycerol and 12 ml/l 
PTM1 were fed in a rate of 0.33 ml/min for 8 h. The expression was then induced using 
100% methanol and 12 ml/l PTM1 with a rate of 0.06 ml/min. Cells were harvested within 32 
h of induction by centrifugation.  
The collected yeast cells were resuspended in low salt buffer containing 100 mM 
sodium phosphate (pH 7.2), 10 % glycerol, 1 mM ethylenediaminetetraacetic acid (EDTA) 
and 1 mM phenylmethanesulfonyl fluoride (PMSF), and then disrupted with a French 
pressure cell. Debris was removed by centrifugation at 1500 x g. The membrane fraction was 
collected and washed twice with high salt buffer containing 20 mM sodium phosphate (pH 
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7.2), 2 M KCl, 10 % glycerol, 1 mM EDTA and 1 mM PMSF, and once with 20 mM 
HEPES-NaOH buffer (pH 7.5) containing 1 mM PMSF as described previously28. The 
membrane protein was then solubilized in 2% (w/v) n-dodecyl-β-D- maltoside (DDM). 
Insoluble material was removed by ultracentrifugation at 100,000 x g. The extracted protein 
was purified with a Co2+-affinity column. The purified protein was loaded into a PD-10 
desalting column (GE Healthcare Bio-Sciences) to remove imidazole and then concentrated 
to 10 mg/ml in a buffer containing 20 mM Na-HEPES (pH 7.5) and 0.03% DDM. The 6xHis 
tag and GFP tag at the C-terminus were then cleaved by adding 1 unit of thrombin (Fisher 
Scientific) per 10 mg of purified LCI1 at room temperature for 20 h. A final purification step 
was performed using a G200 size exclusion column loaded with buffer solution containing 
20 mM Na-HEPES (pH 7.5) and 1.1% n- octyl-β-D-glucopyranoside (β-OG). The purity of 
the LCI1 protein (>95%) was judged using 15% SDS-PAGE stained with Coomassie 
Brilliant Blue. The purified protein was then concentrated to 10 mg/ml in a buffer containing 
20 mM Na-HEPES (pH 7.5) and 1.1% β-OG.  
 
Crystallization of C. reinhardtii LCI1
Crystals of the LCI1 protein were obtained using hanging-drop vapor diffusion. The 
LCI1 crystals were grown at room temperature in 24-well plates with the following 
procedures. A 0.5 µl protein solution containing 10 mg/ml LCI1 in 20 mM Na-HEPES (pH 
7.5) and 1.1% (w/v) β-OG was mixed with a 0.5 µl of reservoir solution containing 18% 
polyethylene glycol (PEG) 2000 MME, 0.1 M sodium citrate (pH 6.5) and 0.01 M NiCl2. The 
resultant mixture was equilibrated against 500 µl of the reservoir solution at 25oC. Crystals of 
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LCI1 grew to a full size in the drops within two months. Typically, the dimensions of the 
crystals were 0.1 mm x 0.1 mm x 0.05 mm. These LCI1 crystals diffracted x-rays to >4 Å 
resolution. To improve the resolution limit, crystals of the mercury derivative were prepared 
by incubating the crystals of LCI1 in solution containing 18% PEG 2000 MME, 0.1 M 
sodium citrate (pH 6.5), 0.01 M NiCl2 and 1 mM HgCl2 for 15 min at 25oC. Cryoprotection 
of these crystals was achieved by raising the glycerol concentration stepwise to 25% with a 
5% increment in each step.  
 
Data collection, structural determination and refinement  
All diffraction data were collected at 100K at beamline 24ID-C located at the 
Advanced Photon Source, using a Platus 6M detector (Dectris Ltd., Switzerland). Diffraction 
data were processed using DENZO and scaled using SCALEPACK29. Crystals of LCI1 
belong to space group P3121 (Table S1). Based on the molecular weight of LCI1 (21.4 kDa), 
the asymmetric unit is expected to contain three membrane protein molecules with a solvent 
content of 64.1%. Three mercury sites were identified using SHELXD30 
 
as implemented in 
the HKL2MAP package31. These heavy-atom sites were refined by single anomalous 
dispersion (SAD) at a resolution of 4 Å using the program AutoSol implemented in 
PHENIX32. Phases were then subjected to density modification, NCS averaging, and phase 
extension to 3.19 Å-resolution using the program RESOLVE33. The resulting phases were of 
excellent quality, which allowed us to trace most of the secondary structural features of the 
three LCI1 molecules within the asymmetric unit. After tracing the initial model manually 
using the program Coot 34, the model was refined using PHENIX32
 
leaving 5% of reflections 
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in Free-R set. Feature-enhanced maps calculated using PHENIX and B-factor sharpening 
maps created using CCP4 were employed to ascertain loop-regions and side chains in the 
structure. Iterations of refinement using PHENIX32and CNS35
 
and model building in Coot34
 
lead to the 3.19 Å-resolution structural model of the LCI1 trimer with excellent geometrical 
characteristics (Table S1).  
 
Docking of CO2  
The program AutoDock Vina26 was used to predict the CO2-binding mode. A 
monomer of the structure of LCI1 with the bound CO2 molecule removed was used for 
docking. A grid of 35 Å x 35 Å x 35 Å with 0.375 Å spacing was calculated around the 
docking area using AutoGrid. The iterated local search global optimizer algorithm was used 
to predict the binding free energies for these compounds.  
 
Native mass spectrometry  
Purified LCI1 protein was buffer exchanged in 200 mM ammonium acetate (pH 8.0) 
and 0.05% lauryldimethylamine oxide (LDAO) using a Biospin-6 column (BioRad) prior to 
mass spectrometry analysis. The protein was directly introduced into the mass spectrometer 
using gold-coated capillary needles prepared in house36. Data was collected on a modified 
QExactive hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific Inc., 
Berman, Germany) optimized for analyzing high mass complexes37. Optimized instrument 
parameters were as follows: capillary voltage 1.2kV, S-lens RF potential 100V, quadrupole 
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selection range between 2,000 and 20,000 m/z, collisional activation in the HCD cell 100V, 
argon pressure in the HCD cell 1.12x10-9 mbar and resolution of the instrument was 
acquired at 17,500 with m/z = 200 (transient time = 64 ms).  
 
Lipid analysis  
Lipid analysis was carried out by following the protocol as described previously38. 
Briefly, intact LCI1 protein was digested with trypsin overnight at 37oC, lyophilized and re-
dissolved in 35% acetonitrile. The peptide/lipid mixture was loaded onto a C18column 
(Acclaim PepMap 100, C18, 75 µm × 15 cm; Thermo Scientific) and separated with a linear 
gradient of 35-100% acetonitrile. The column eluent was then delivered to a hybrid LTQ-
Orbitrap XL mass spectrometer (Thermo Scientific) that was coupled to the column. The 
LTQ-Orbitrap XL was operated in negative ion mode and in data-dependent acquisition set-
up to perform five MS/MS scans per MS scan. Survey full-scan MS spectra were acquired in 
the orbitrap (m/z 350-2000) with a resolution of 60,000.  
 
Steered Molecular Dynamics  
A 120 Å x 120 Å palmitoyl-oleyl-phosphatidylethanolamine (POPE) membrane 
bilayer was constructed using the membrane builder plugin in NAMD39 with the membrane 
normal parallel to the z-axis. The protein was embedded in the membranesuch that its 
threefold symmetrical axis was perpendicular to the membrane plane. The system was then 
solvated by the addition of 5 Å of water layers on both sides of the lipid bilayer. Na+
 
and Cl-
 
  
72 
ions were also included to ensure the balance of charges, resulting in a total number of 
112,470 atoms (112,472 atoms in the case of bicarbonate) in the system. After, the system 
was equilibrated at 10K and the temperature was slowly increased to 310 K in steps of 1 K 
per 1 ps each step for 200,000 steps. A harmonic restraint of 1 kcal/mol Å2
 
was applied to the 
protein during the process of raising the temperature. A 100 ps equilibration run was then 
performed at 310K, in which all atoms were allowed to move freely. Langevin dynamics (1 
ps-1
 
damping coefficient) was used to maintain the constant temperature. A cutoff distance of 
12 Å was used to mimic the effect of van der Waals interactions. A periodic boundary 
condition was imposed using the particle mesh Ewald method with a 1 Å grid spacing to 
evaluate long-range full electrostatic interactions. In all simulations, NAMD39 with 
CHARMM27 parameter set40,41 was used. The topology and parameter files for CO2 were 
generated using the SwissParam server41,42 and those for bicarbonate ion were obtained using 
the Paratool plugin in VMD43.  
SMD simulations were carried out to investigate the transport pathway of CO2 and 
HCO3-.
 
These ligands were placed accordingly at one end of the channel. Constant velocity 
steered MD (cv-SMD) was applied. Specifically the carbon atom of CO2 or HCO3-
 
was 
pulled in a direction perpendicular to the membrane plane (Z-direction) using a harmonic 
constraint at a velocity of 30 Å/ns with a force constant (!) of 5 kcal mol-1Å-2. To prevent 
overall translational motion of the system, specific residues at the periphery of the 
periplasmic side (T39, V59, P73, N135 and D143) and cytoplasmic side (V10, V99, M107 
and S170) of the protein were harmonically restrained with a force constant of 5 kcal/mol Å2
 
in the z-direction.  
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      Protein data bank accession code 
Atomic coordinates and structure factors for the structure of LCI1 have been 
deposited at the RCSB Protein Data Bank with an accession code 5TSM. 
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Figure S1a. Stereo view of the experimental electron density map of the LCI1 trimer at a resolution of 3.19 Å. The electron 
density map is contoured at 1.2σ. The Cα traces of the LCI1 molecule in the asymmetric unit are showed as colored lines. 
Anomalous signals of the three Hg binding sites (contoured at 3σ) found in the asymmetric unit are colored red.  
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Figure Sb1. Representative section of electron density near helices TM3 and TM4 of LCI1 protomer. The solvent!flattened 
electron density (50–3.19 Å) is contoured at 1.2σ and superimposed with the final refined model (green, carbon; red, oxygen; 
blue nitrogen; yellow, sulfur) 
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Figure S2. Identification of the bond lipids of lipid-LCI1 complexes by native MS. Lipid analysis showed the two most 
abundant precursor ion peaks at m/z 673.48 and 699.49 are PA(16:0/18:1) and PA (18:1/18:1) respectively.  
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Table S1.  Data collection, phasing and structural refinement statistics of LCI1. 
Data set LCI1-Hg derivative 
Data collection  
Wavelength (Å) 1.008 
Space group P3121  
Cell constants (Å)  
a 85.24 
b 85.24 
c 209.78 
α, β, γ (°) 90,90,120 
Resolution (Å) 50-3.19 (3.32-3.19) 
Completeness (%) 99.9 (100.0) 
Total reflections 1,214,125 
Unique reflections 15,317 
CC1/2(outer shell) 0.51 
Redundancy 9.3 (9.6) 
Rpim (%) 4.2 (52.1)  
!I/σ(I)"  19.83 (1.55) 
Phasing  
Number of sites 3 
Figure of merit (acentric/centric) 0.91/0.85 
Refinement  
Rwork (%) 21.08 
Rfree (%) 28.41 
B-factors  
Overall(Å2) 24.52 
Chain A/B/C 22.74/23.14/27.44 
Rms deviations  
Bond (Å) 0.012 
Angles (o) 1.224 
Ramachandran analysis  
Most favored (%) 98.0 
Allowed (%) 2.0   
Disallowed (%) 0.0 
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CHAPTER IV 
STRUCTURAL STUDY OF RECEPTOR LIKE KINASE FERONIA OF ARABIDOPSIS 
THALIANA 
 
Introduction 
Unlike animals, plants are unable to mobilize themselves to adapt the environment 
changes. Thus, plant cells have developed the strategies that involve signal perception and 
transduction across the cell membrane. On the surface of the plasma membrane, which is the first 
line of the defense and signal reception of cells, a large group of transmembrane proteins are 
responsible for receiving incoming signals and stimulate the cell interior reaction pathways. 
These receptor-like kinases (RLK) are single transmembrane helix proteins with an extracellular 
receptor domain for signal reception and a cytoplasmic kinase domain that induces cellular 
responses by phosphorylating downstream targets. In Arabidopsis thaliana, there are more than 
610 RLK homologs encoded in its genome but only few of them have known function as well as 
their ligands and signaling targets.1,2  
Among the RLK superfamily, a group of 17 proteins led by FERONIA have been 
identified by theirextracellular sensory domain and are found to be involved in growth and 
reproduction.3,4 FERONIA was first found to be regulator in fertilization and pollen 
perception.5,6,7 The follow-up functional studies onFERONIA indicated that feronia mutants 
inhibited the root growth and root hair elongation in seedling phenotypes.8,9 Also,  feronia 
seedlings are hypersensitive to abscisic acid (ABA), which plays a crucial role in plant stress 
response, which significantly reduced the root growth in the presence of ABA.9,10 In addition, 
studies showed that plants are more resistant to certain bacterial and fungal pathogens in the 
absence of functional FERONIA.11,12,13 These studies suggested that FERONIA precipitates in 
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various signaling pathways in plant growth, reproduction, pathogen response, and environmental 
stress response.4 As for the signal reception of FERONIA, a group of a group of plant growth 
peptide hormones, which involve in root growth response, are believed to be the ligands of 
FERONIA. Rapid alkalization factors (RALFs) were found in many plant species and showed 
inhibition of root growth.14,15 In particular, RALF1 has been reported the capability of interacting 
with FERONIA binding domain thus induced phosphorylation at its C-terminal region and 
feronia mutated seedlings are insensitive to RALF1 treatment, which suggested RALFs are the 
ligands of FERONIA.9,16  
FERONIA consists of an extracellular sensory domain and a cytoplasmic kinase domain 
connected by single transmembrane helix. The extracellular sensory domain possesses two 
malectin-like domains, which distinguishes it from other members of RLK superfamily. Malectin 
is an animal protein known to bind dimeric and oligomeric glucose,17 which suggests that 
carbohydrates are possible ligand candidates of FERONIA and its homologs. Several crystal 
structures of the sensory domain in RLK superfamily have been reported,18,19,20,21 which 
provided insights into signal reception mechanism in RLK superfamily. However, these 
structures provided less information to understand the sensory mechanism of FERONIA due to 
its unique extracellular domain. Thus, the mechanism of ligand-protein interaction and 
downstream regulation of FERONIA remain elusive. In this study, we used structural and 
biochemical approaches to explore the function of the FERONIA receptor kinase and its peptide 
ligands and its downstream transcriptional factor.  (nomenclature is usually “signal peptide”) 
Figure 1. Conserved domains of FERONIA. 
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Results 
 
Expressing FERONIA sensory domain in E. coli. 
To prepare the FERONIA sensory domain for crystallization, we began by modifying the 
N-terminus MBP-fused FERONIA sensory domain expression construct provided by Dr. Yin’s 
group (GDBC, Iowa State university) by introducing a thrombin cleavage site between the MBP 
and FERONIA sensory domain. The resulting fusion protein was over-expressed in E. coli and 
purified using an amylose column. However, during the thrombin cleavage test, the fusion 
protein remained intact in 4 °C after treating thrombin for 16 hours. At room temperature, 
degradation of the sample was observed, which suggested the FERONIA sensory domain was 
not stable at room temperature. While MBP tags are known to highly promote the expression 
level of the target protein, it is not guaranteed that the expressed protein is functional and well 
folded. Based on the proteolysis results, the expressed FERONIA might not be folded properly. 
 
Figure 2. The proteolysis assay of purified MPB-
FERONIA sensory domain by thrombin. 
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Refolding of FERONIA sensory domain 
             To avoid over-expressing poorly-folded protein, we removed the MPB from the 
construct and cloned the full-length FERONIA sensory domain into expression vector pET15b. 
The expression test showed the target protein was highly expressed but aggregated in an 
inclusion body. We were able to obtain a soluble form of the FERONIA sensory domain by the 
rapid dilution method. However, size exclusion chromatography indicated that the protein was 
aggregated. After several attempts with different refolding methods, the aggregation issue was 
still unable to be resolved.     
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Figure 3. a) Schematic depiction of FERONIA sensory domain construct used for 
expression. b)  The SDS-page analysis of the refold FERONIA sensory domain  
and c) the elusion diagram of size exclusion chromatography.  
a) 
b) c) 
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Expressing two FERONIA melactin domains in E. coli. 
Based on the results from the MPB fused construct and refolding attempts, it is unlikely 
that stable full length FERONIA sensory domain protein which is suitable for crystallization can 
be produced. However, there are two melactin sub-domains that have been identified in the 
FERONIA sensory domain. It would be a good alternative way to understand the architecture of 
FERONIA sensory domain by determining the structure of the two melactin domains. To test the 
expression of two melactin domains of FERONIA in E. coli, we generated the N-terminus 
6xHis-GFP fused constructs for the each melactin domains. The expression results from Western 
blots and fluorescent intensity indicated low yield and degradation of the two proteins. It is 
suggested that E. coli might not be a suitable expression system for expressing the FERONIA 
sensory domain.  
 
 
 
Figure 4. a) The western blot and b) GFP fluorescent intensity of the GFP fused FERONIA 
melactin domains expression test with different E. coli strains and temperature.! 
b) a) 
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Expressing FERONIA sensory domain in P. pastoris. 
           To investigate the expression of FERONIA sensory domain in P. pastoris we started by 
checking the solubility of the expressed protein. The western blot result of yeast cell lysate 
indicated that the FERONIA sensory domain can be expressed and is soluble in P. pastoris. 
However, the size corresponding to the signal was two times larger than the calculated size of the 
FERONIA sensory domain. This size difference might cause by post-translational modification 
in yeast. There are ten predicted glycosylation sites found in the FERONIA sensory domain. It is 
possible that the protein was glycosylated while being expressed in yeast. 
For the scaled-up expression, we used two different approaches to select the cell line that yielded 
the highest expression of recombinant protein. By fusing alpha-factor, the secretion peptide that 
can export the protein of interest out of the yeast cell, it should be possible to harvest the 
FERONIA sensory domain from the growth medium without disrupting the yeast cell. However, 
the western blot failed to detect the protein in the medium due to low yield. To corroborate this, 
we generated a C-terminus GFP fused construct which is widely used for checking membrane 
protein expression in yeast. The fluorescent intensities of selected colonies were significantly 
lower than the positive control after 48 hours of induction. The results suggest a low yield of 
FERONIA sensory domain in P. pastoris.
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c) 
c) 
a) 
Figure 5. a) The western blot analysis of expression FERONIA sensory domain in P. pastoris. Schematic depiction of 
the construct used and GPF fluorescence intensity results for expression test of a) C-terminus GFP fused FERONIA 
sensory domain and b) N-terminus MBP, C-terminus GFP fused FERONIA sensory domain. 
b) 
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Crystallization of FERONIA protein kinase domain 
Based on the secondary structure analysis and crystal structure of the homolog (PDBID: 
2QKW), we generated a construct of the FERONIA protein kinase domain (496-818) excluding 
the flexible loop containing phosphorylated sites at the C-terminus into the expression vector 
pET15b with a C-terminal His tag for protein crystallization. However, no colony appeared on 
the ampicillin selection plate after transformation which was consistent with the observation in 
Dr. Yin’s group when they attempted to express MBP fused full length C-terminus FERONIA in 
E. coli. The results may indicate that the FERONIA PK domain is toxic to E. coli.  
To remove the toxicity, we introduced single-site mutagenesis at nucleotide binding 
domain (K565R) to deactivate the kinase activity. The resulting construct exhibited a good yield 
of the recombinant protein. The homogeneity of the protein was verified by the size exclusion 
chromatography. The sample was pre-incubated with ATP, ADP, or AMP before being subjected 
to crystallization screening). Crystals of FERONIA PK domain were observed in the AMP co-
crystallization drop. After optimization, the best diffraction of the crystals extended up to 4Å. 
However, the overall diffraction patterns of the crystals were smeared and exhibited the behavior 
of multi-crystals. The following crystallization optimization and screening attempts of 
FERONIA PK domain were unable to resolved the problem. We then rebuilt the construct by 
removing a predicted flexible loop and N-terminal His tag followed by a thrombin cleavage site 
to increase the protein integrity. Still, no crystal was observed in the crystal screening. 
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Figure 6. a) The construct used for FERONIA kinase domain crystallization. b) Gel 
filtration and c) SDS-page analysis of the purified FERONIA kinase domain. 
c) 
a) 
b) 
93 
  
 Figure 7. a) The crystal and b) the X-ray diffraction pattern of FERONIA kinase 
domain. 
a) b) 
94 
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Crystallization of transcriptional factors RD26 
Based on the study of Dr. Yin’s group (data unpublished), FERONIA inhibits the 
expression of the drought response related transcription factor RD26 which plays an important 
role in Abscisic acid (ABA) pathway. We expressed and purified the DNA binding domains of 
RD26. The purified protein was then subjected to crystal screening. The crystals of RD26 DNA 
binding domain were apparent after two weeks and grew to full size after a month. The crystals 
were unable to diffract beyond 7Å. Additionally, we tried to study the DNA protein complex by 
crystallography; however, no crystal was carried out during the crystal screening. 
Figure 8. The crystal and the X-ray diffraction pattern of RD26 DNA binding domain. 
  
Figure 9.a) Schematic depiction of RD26 DNA binding domain construct used for crystallization. b) The western 
blot results of RD26 expression in E. coli. c) The SDS-page analysis of His tag removal and gel filtration of the 
purified RD26 DNA binding domain.  
 
a) 
b) 
96 
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Purification of RALF and RALF23 
The plant growth peptide hormone RALF1 is believed to be one of the ligands for the 
FERONIA receptor kinase. Studies have shown that RALF1 inhibited root growth in a 
seeding growth assay. Also, RALF1 stimulated the phosphorylation of the C-terminus of 
FERONIA, which might lead to a down-regulation of AHA2, a H+-ATPase that plays an 
important role in yeast growth and root growth in plant. In collaboration with Dr. Yanhai 
Yin’s group, we focused on studying a RALF-like peptide RALF23 from both a functional 
and structural perspective. In our lab, we expressed C-terminus His tagged RALF1 and 
RALF23 in E. coli with MBP fused construct and purified in combined with immobilized 
metal affinity chromatography and reversed phase chromatography. The purified RALF and 
RALF23 were then subjected to crystal screens and bio-functional studies in Dr. Yin’s group. 
However, we were unable to crystallize RALF or RALK23 after several attempts.  
Figure 10. a) The SDS-page 
analysis of the purified MBP 
fused RALF1 and RALF23. 
b) The SDS-page and western 
blot result for RALF23 after 
HPLC 
 
a) b) 
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Conclusion and discussion 
 
In this study, we first utilized different methods of expression and purification 
protocols to obtain recombinant FERONIA sensory domain for crystallization. Using the E. 
coli system, which is the most established prokaryotic expression system, we were able to 
over-express the FERONIA sensory domain as inclusion bodies or MBP-fused protein in 
soluble form. However, the MBP-fused protein appeared to be misfolded, resulting in 
complete degradation during thrombin treatment. For the attempts of refolding recombinant 
protein from solubilized inclusion bodies, only aggregated protein was observed in size 
exclusion chromatography after the refolding process. The results suggested that the 
expression of FERONIA sensory domain in E. coli failed to retain its structural integrity, 
which is a common issue for expressing recombinant eukaryotic proteins using prokaryotic 
expression systems. Protein maturation in eukaryotic organisms, especially membrane 
proteins, undergoes a more sophisticated process compared with expression in prokaryotic 
organisms. In eukaryotes, membrane proteins are synthesized at the surface of endoplasmic 
reticulum (ER) and folded into their matured form with the help of chaperones in the ER. 
The folded proteins are translocated to the Golgi apparatus for further processing before 
being transported to their final destinations. During the process proteins are modified to their 
final functional forms by post-translation modifications (PTM) such as phosphorylation and 
glycosylation. However, prokaryotic expression systems such as E. coli cannot perform this 
PTM and lacks the necessary enzymes and chaperones for proteins to mature. Although the 
previous studies indicated that the MBP-fused FERNOIA sensory domain exhibited the 
capability of binding ligand RALF116, it does not guarantee that the sample was suitable for 
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crystallization. The overexpressed protein might be heterogeneous or partially folded, 
however, the essential condition for protein crystallization is its homogeneity. 
To acquire the proper folded and homogenous protein, we tested the expression of 
FERONIA sensory domain in eukaryotic expression system Pichia pastoris. By the western 
blot assay, a potentially post-translationally modified protein was observed, which agreed 
with the prediction on the open protein database (http://www.uniprot.org). However, we were 
unable to produce enough sample for analysis due to the low expression level in P. pastoris. 
This suggested the expression system might not be compatible for expressing the target 
protein. To overcome expression problems of the FERONIA sensory domain, a different 
expression system in higher evolved species might be required. The previous structural 
studies of the sensory domain in the RLK superfamily suggested that insect expression 
systems such as Sf-9 and high-five cells may be preferable for producing recombinant 
protein for crystallization.18,19,20,21 Recently, a new expression system in plant has been 
proposed,22 which could be the better approach for expressing plant proteins in future studies.  
On the other hand, we crystallized the FERONIA kinase domain in the presence of 
AMP. The crystals diffracted to 5 Å overall but the diffraction patterns were not of an 
analyzable quality. Also, we were able to crystallize the DNA binding domain of RD26, 
which is a possible downstream target of FERONIA signaling pathway. However, the 
diffraction could not be extended higher than 7 Å. After extensive crystallization screening 
and condition optimization, the resolution of these crystals was still far from 4 Å, which is 
the cut off resolution of determining side chain location. One of the possible reasons for the 
poor diffraction is the disturbance in the crystal lattice. This may be due to the fact that 
proteins are not tightly packed while forming crystals, allowing other substances like water 
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molecules and small chemicals that are not involved in crystal formation into the crystals. 
The loose packing of the protein crystal lattice also permits spaces for the flexible domains of 
the protein to disorient the crystal, resulting in loss of high-resolution information in the 
diffraction pattern. We removed the flexible regions on the target proteins by secondary 
structure prediction23 and protein engineering. Nevertheless, the new constructs failed to 
crystallize. We then attempted to co-crystallize RD26 DNA binding domain with its target 
DNA sequence,24 hoping that the complex could stabilize the packing. Unfortunately, little 
progress has been made. One alternative method for acquiring structural information is to 
screen suitable candidates for crystallization among the closest homologs. By crystallizing 
the homologs which function similarly in the different species, we can utilize the homolog 
structure as the template to model the structure of the target protein for structural analysis.  
Finally, we have shown the purification of two hormone peptides RALF1 and 
RALF23 which are the ligands of FERONIA. Currently, the protein samples are being 
subjected to growth phenotype assay in Dr. Yin’s group to study the signal response of 
FERONIA. Our lab is currently working on the co-crystallization of RALFs and a functional 
FERONIA sensory domain which may provide structural insight into understanding the 
sensory mechanism of FERONIA. 
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Methods 
 
Purification of MBP-FERONIA sensory domain 
A short linker and a thrombin cleavage site was placed between the MBP and 
FERONIA sensory domain in the vector provided by Prof. Yin’s group. The construct was 
over-expressed in E. coli BL21 cells. Cells were grown in 6L of LB medium with 50 µg/ml 
kanamycin at 37 °C. The cultures were then induced with 0.2mM IPTG overnight at room 
temperature. The cells were pelleted and suspended in 100 ml of ice-cold buffer containing 
20 mM Na-HEPES (pH 7.5), 150 mM NaCl and 10% glycerol. The cells were then lysed and 
the cell debris was removed by centrifugation for 45 min at 4 °C and 36,000 rpm. The crude 
lysate was loaded onto a 3-ml amylose resin (NEB) pre-equilibrated with the lysis buffer. 
The column was washed with buffer 20 mM Na-HEPES (pH 7.5), 150 mM NaCl and eluded 
with the same buffer containing extra 10mM maltose. The maltose was remove by dialysis 
against the buffer 20 mM Na-HEPES (pH 7.5), 150 mM NaCl for 4L. The purity of the 
protein was judged using 12.5% SDS-PAGE stained with Coomassie Brilliant Blue.  
 
Refolding of FERONIA sensory domain 
FERONIA sensory domain protein was cloned into vector pET15b containing a 
6xHis tag at the N-terminus was over-expressed in E. coli BL21 ∆AcrB cells. Cells were 
grown in 3L of Luria broth (LB) medium with 100 µg/ml ampicillin at 37 °C. The cultures 
were then induced with 0.2mM IPTG for 3 hours at 37 °C. The cells were pelleted and 
suspended in 100 ml of ice-cold buffer containing 20 mM Na-HEPES (pH 7.5), 150 
mM NaCl and 10% glycerol and then lysed with a French pressure cell. Cell debris 
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containing inclusion body was collected by centrifugation for 45 min at 4 °C and 36,000 rpm. 
The pellet was then homogenized and washed with 1% Triton X-100 two times to remove 
detergent soluble impurities and left the pure inclusion body. The resided Triton X-100 was 
removed by homogenized and washed with the final buffer 20 mM Na-HEPES (pH 7.5),150 
mM NaCl. The pure inclusion bodies were then dissolved in the final buffer containing 
desired denaturant (6M Guanidine·HCl or 8M Urea) for 30 minutes at room temperature by 
stirring. The insoluble portion was removed by centrifugation and the denatured protein was 
loaded onto a Hi-Trap Ni2+-chelating column (GE Healthcare) pre-equilibrated with the 
denaturant buffer. The column was washed with the imidazole gradient and eluded with 
denaturant buffer with extra 300 mM imidazole. The purified denatured sample was ready for 
different refolding methods. 
 
The refolding attempts of FERONIA sensory domain were carried out by rapid 
dilution and in-column refolding methods. For the rapid dilution method, the purified 
denatured protein solution was diluted into the refolding buffer (20 mM Na-HEPES (pH 7.5), 
150 mM NaCl, 10mM β-Mercaptoethanol and 0.5M L-arginine) to the final concentration of 
1mg/ml by vigorous mixing. The diluted sample was then dialysis against 4L of final buffer 
(20 mM Na-HEPES (pH 7.5), 150 mM NaCl) to remove denaturant and additives which may 
inhibit protein crystallization. As for the in-column refolding method, the purified protein 
was retained in the Ni2+ column without elusion. The refolding process was performed by 
washing the column with a step-wise decreased of denaturant as following, 10ml of final 
buffer (20 mM Na-HEPES (pH 7.5), 150 mM NaCl, 10mM β-Mercaptoethanol) containing 
6M, 4M, 2M, 1M Urea respectively. The column was washed with 20ml final buffer before 
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elusion. The qualities of the refold FERONIA sensory domain in different methods were 
verified by size exclusion chromatography.   
 
Expression screen of FERONIA sensory domain in P. pastoris 
The transformation protocols of both C terminus GFP fused FERONIA sensory 
domain and N terminus MBP, C terminus GFP fused FERONIA sensory domain into P. 
pastoris generally followed the Pichia Expresstion kit (Invitrogen). In brief, the genes 
containing the fusion protein were cloned into expression vector pPICZ-A (Invitrogen) and 
purified using High-Speed Plasmid Mini kit (IBI Scientific). 10 µg of DNA was linearized by 
treating with enzyme Pme1 (NEB) in 37oC for 5 hours. The reaction was disrupted by heat 
inactivation for 20 min at 65oC. Electrocompetent cells SMD1168H were prepared following 
the protocol outlined in the Pichia Expresstion kit (Invitrogen). Linearized plasmid DNA was 
incubated with 100 µL of electrocompetent SMD1168H on ice and electroporated using a 
BioRad Gene Pulser. The cells were plated on YPDS containing 200 µg/ml and 500 µg/ml 
zeocin. The plates were then placed in the incubator at 29 oC until the colonies grown to 
desirable size (approximately 3 days).     
 
The colonies for expression screening were suspended in 60 µL BMGY(2.0% 
Peptone, 1.0% Yeast extract,100mM Potassium phosphate pH 6.0, 1.34% Yeast Nitrogen 
Base (w/o AA), 0.4µg/mL Biotin, 1.0% Glycerol) separately.1 µL of each suspended 
colonies were set on the induction plate containing BMMY(2.0% Peptone, 1.0% Yeast 
extract, 100mM Potassium phosphate pH 6.0, 1.34% Yeast Nitrogen Base (w/o AA), 
0.4µg/mL Biotin, 0.5% Methanol) at the designated positions. The expression levels of each 
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colony were verified by comparing the GFP fluorescent signals using Typhoon FLA 9500 
(GE Healthcare) after 48 hours of induction at 29 oC. 
 
Purification and crystallization of FERONIA kinase domain 
FERONIA kinase domain (PK) protein containing a 6xHis tag at the C terminus and a 
thrombin cleavage site was over-expressed in E. coli BL21 cells. Cells were grown in 3L of 
Luria broth (LB) medium with 50 µg/ml kanamycin at 37 °C. The cultures were then induced 
with 0.2mM IPTG overnight at room temperature. The cells were pelleted and suspended in 
100 ml of ice-cold buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl and 10% 
glycerol. The cells were then lysed with a French pressure cell. Cell debris was removed by 
centrifugation for 45 min at 4 °C and 36,000 rpm. The crude lysate was loaded onto a 3-ml 
Hi-Trap Ni2+-chelating column (GE Healthcare) pre-equilibrated with the lysis buffer. The 
column was washed with the following buffers, 50mL of 20 mM imidazole (pH 7.2), 150 
mM NaCl, and 20 mM Tris-HCl (pH 7.5), 20mL of 60 mM imidazole (pH 7.2), 150 
mM NaCl, and 20 mM Na-HEPES (pH 7.5). FERONIA PK domain was then eluted using 
20mL of 300 mM imidazole (pH 7.2), 150 mM NaCl, and 20 mM Tris-HCl (pH 7.5). The 
purity of the protein was judged using 12.5% SDS-PAGE stained with Coomassie Brilliant 
Blue. The His tag was removed by Ni-NTA column after treating with thrombin for 16h at 4 
°C. The sample protein was further purified with size exclusion chromatography with 
superdex 200 column, resulting a single homogenous peak which is suitable for 
crystallization. 
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Crystals of the FERONIA PK domain were obtained using sitting-drop vapor 
diffusion. The crystals were grown at room temperature in 96-well plates with the following 
procedures. The final concentration of 2mM AMP was mixed with 10mg/ml FERONIA PK 
domain and incubated on ice for 30 minutes before crystallization. A 0.5 µl protein solution 
containing was mixed with a 0.5 µl of reservoir solution containing 12-16% PEG 2000MME, 
0.1M Na-Citrate 6.0. The resultant mixture was equilibrated against 500 µl of the reservoir 
solution at 25°C. Crystals of FERONIA PK domain grew to a full size in the drops in two 
weeks. The dimensions of the crystals were 0.05 mm x 0.2 mm x 0.1 mm. Cryoprotection of 
these crystals was achieved by raising the glycerol concentration stepwise to 25% with a 5% 
increment in each step. The diffraction data were collected at 100K at beamline 24ID-C 
located at the Advanced Photon Source, using a Platus 6M detector (Dectris Ltd., 
Switzerland).  
 
Purification and crystallization of RD26 DNA binding domain 
RD26 DNA binding domain protein was cloned into vector pET15b containing a 
6xHis tag at the N terminus and a thrombin cleavage site. The construct was over-expressed 
in E. coli C43 codon plus ∆AcrB cells. Cells were grown in 3L of LB medium with 100 
µg/ml ampicillin at 37 °C. The cultures were then induced with 0.2mM IPTG for 3 hours at 
37 °C. The cells were pelleted and suspended in 100 ml of ice-cold buffer containing 20 
mM Na-HEPES (pH 7.5), 150 mM NaCl and 10% glycerol. The cells were then lysed with a 
French pressure cell. Cell debris was removed by centrifugation for 45 min at 4 °C and 
36,000 rpm. The crude lysate was loaded onto a 3-ml Hi-Trap Ni2+-chelating column (GE 
Healthcare) pre-equilibrated with the lysis buffer. The column was washed by imidazole 
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gradient in buffer 20 mM Na-HEPES (pH 7.5), 150 mM NaCl and eluded with the same 
buffer containing extra 300 mM imidazole. The purity of the protein was judged using 12.5% 
SDS-PAGE stained with Coomassie Brilliant Blue. The His tag was removed by Ni-NTA 
column after treating with thrombin for 16h at 4 °C. The sample protein was further purified 
with size exclusion chromatography with superdex 200 column. 
 
Crystals of the RD26 DNA binding domain were obtained using hanging-drop vapor 
diffusion. The crystals were grown at room temperature in 24-well plates with the following 
procedures. A 0.5 µl protein solution containing 6 mg/ml RD26 DNA binding domain in 20 
mM Na-HEPES (pH 7.5) and 150mM NaCl was mixed with a 0.5 µl of reservoir solution 
containing 3M NaCl, 0.1M Bis-Tris 6.0. The resultant mixture was equilibrated against 500 
µl of the reservoir solution at 25°C. Crystals of RD26 DNA binding domain grew to a full 
size in the drops in one month. The dimensions of the crystals were 0.1 mm x 0.1 mm x 0.1 
mm. Cryoprotection of these crystals was achieved by incubating the crystals in reservoir 
solution containing additional 25% glycerol for 1 minute. The diffraction data were collected 
at 100K at beamline 24ID-C located at the Advanced Photon Source, using a Platus 6M 
detector (Dectris Ltd., Switzerland).  
 
Purification of RALF1 and RALF23 
RALF1 and RALF23 core domain proteins containing a His6 tag at the C terminus 
were cloned into vector pMAL-c5x and were overproduced in Escherichia coli BL21 cells. 
Cells were grown in 3 liters of Luria broth (LB) medium with 50 µg/ml kanamycin at 37 °C. 
The cultures were then induced with 0.2mM IPTG overnight at room temperature. The 
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pelleted cells were suspended in 50 ml of ice-cold buffer containing 20 mM Na-HEPES (pH 
7.5) and 150 mM NaCl. The cells were then disrupted with a French pressure cell. Cell debris 
was removed by centrifugation for 45 min at 4 °C and 36,000 rpm. The crude lysate was 
loaded onto a Hi-Trap Ni2+-chelating column (GE Healthcare) pre-equilibrated with the lysis 
buffer. To remove the impurities the column was washed with the lysis buffer containing 
additional 20mM Imidazole. MBP fused RALF1 and RALF23 core domain proteins were 
then eluted using the same buffer with 30mM Imidazole. The purity of the proteins was 
judged using 12.5% SDS-PAGE stained with Coomassie Brilliant Blue. The MPB was then 
cleaved by 1U thrombin (GE Healthcare Bio-Sciences, Pittsburgh, PA) per 10mg of 
protein for 16h at 4 °C. The Ralf and Ralf23 core domain were then further purified by 
HPLC with the C8 reverse phase column in 0.1% TFA and eluted with acetonitrile gradient. 
The corresponding fractions were then freeze-dried and stored at -20°C. 
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CHAPTER V  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Mycobacterium tuberculosis possesses a unique cell wall, which is known to play a 
crucial role in virulence and antimicrobial resistance. In M. tuberculosis, the MmpL 
family, a group RND transporters that can be only found in mycobacteria family, 
contributes to cell wall biosynthesis by exporting fatty acid derivatives. The expression of 
the M. tuberculosis MmpL proteins is controlled by a complicated regulatory network 
system. In Chapter II, we demonstrated two high-resolution crystal structures of two 
forms of the TetR-family transcriptional regulator Rv0302, which was predicted to 
regulate the expression of multiple MmpL proteins. Comparison of the two Rv0302 
crystal structures suggested that the conformational changes leading to disengagement 
from DNA consist of a rigid body rotational motion within the dimer interface of the 
regulator. Using fluorescence polarization and electrophoretic mobility shift assays, we 
demonstrated the recognition of promoter and intragenic regions of multiple MmpL 
genes by Rv0302. In addition, the isothermal titration calorimetry and electrophoretic 
mobility shift experiments indicate that fatty acids may be the natural ligand of this 
regulator.  
 Although our study has shown the possibility that Rv0302 regulates multiple MmpL 
genes in vitro, the real interactions of these genes and Rv0302 cells are yet to be 
determined. Besides, palmitic acid, which is the product of the fatty acid synthesis 
pathway, is the probable nature ligand of Rv0302; it is interesting to explore if Rv0302 is 
involved in regulating fatty acid synthesis. To study the regulation of Rv0302 in vivo, one 
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of the approaches could be to measure the change of mRNA levels of different genes in 
M. tuberculosis while Rv0302 is mutated.  
The large cavity in the ligand binding domain of form I Rv0302 revealed the 
structural insight of ligand induced conformational change, providing the information for 
the ligand-protein interaction. This information can be subjected to future ligand 
discovery by the combination of high throughput docking simulation and biochemical 
analysis. Furthermore, the same strategy can lead to inhibitor development of this 
regulators, which occupy the ligand binding site without inducing disengage the protein 
from DNA and thus disrupting the expression of MmpL transporters. On the other hand, 
it is known that the ligands of transcriptional regulators are likely to be the substrates of 
their regulating targets. Therefore, exploring the possible ligands of Rv0302 could 
contribute to understanding the function of MmpL transporters as well as their roles in 
pathogenicity and antimicrobial resistance. In summary, the study of this regulator might 
provide a different perspective for future study of MmpL family and the cell wall 
formation of M. tuberculosis.     
Carbon acquisition via photosynthetic CO2 assimilation is responsible for the 
production of essentially all biological carbon and thus is essential for almost all life on 
earth. Phytoplankton such as microalgae, contribute more than half of all global 
photosynthetic CO2
 
assimilation and require a carbon concentrating mechanism (CCM) 
to survive and flourish. Despite the importance of photosynthetic CO2
 
assimilation and of 
microalgae specifically, it still is not fully understood how microalgae scavenge 
atmospheric CO2. In Chapter III, we present a crystal structure of the Chlamydomonas 
reinhardtii LCI1 channel, which has shown a direct involvement in inorganic carbon 
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transport by the CCM. Combined with X-ray crystallography, mass spectrometry, and 
computational simulation, our data indicate that the LCI1 membrane protein forms a 
trimeric assembly, in which each protomer conducts uncharged CO2
 
and shuttles this 
inorganic carbon species across the cell membrane. LCI1 does not belong to a well-
characterized transporter family or transport inorganic carbon by known carrier-mediated 
transporters. LCI1 not only is the first of these CCM-related transporters to have it 
structure solved, but it also represents a completely novel type of transporter. 
While we have determined the crystal structure of a novel membrane transporter 
LCI1 and elucidated its structural details, the function and transportation mechanism of 
this protein remain elusive. Hence, future work should focus on investigating the 
biofunctional importance of LCI1 in CCM combined with structural information. The 
structural analysis and computational simulation of the crystal structure suggested that 
LCI1 might transport CO2 but –HCO3, however, there is no experimental evidence in vitro 
or in vivo to support analysis. Due to pH dependence of the interconversion between CO2 
and –HCO3, which the conversion is in favor of CO2 in acidic environment and –HCO3 in 
alkaline environment, one of the plausible methods is to conduct the growth phenotype 
assay in C. reinhardtii and compare the difference between the wild type and LCI1 
mutant at different pH. Moreover, the structure of LCI1 has revealed a small and rigid 
soluble domain that allows no conformational change for scavenging substrate from the 
environment. It is unlikely that the LCI1 can concentrate Ci under very low Ci 
concentration without the support from other proteins. Therefore, the pull-down assay of 
LCI1 against cell lysate could be performed to identify the proteins that interact with 
LCI1 and investigate the involvement of these proteins in CCM.       
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     Alternatively, the proteoliposome related assays may offer a new route to inspect 
transport mechanism LCI1 in vitro. By incorporating the protein into the liposome, the 
proteoliposome mimics the natural environment of the membrane transporter. In addition, 
various substrate specific indicators can be encapsulated in the proteoliposome which 
serve as suitable markers for recognizing substrate transport. In our lab, we currently 
focus on stop-flow proteoliposome assay incorporated with pH sensitive indicator to 
study the transport mechanism of LCI1 as well as residues involved in substrate 
transportation by site-directed mutagenesis.             
Structure determination of membrane protein in higher evolved species is always a 
great challenge for X-ray crystallography. The major obstacle is not the complexity of 
protein structure but the acquisition of the well-folded recombinant protein for 
crystallization. In Chapter IV, we demonstrate our efforts of determining the structure of 
a plant RLK protein FERONIA in Arabidopsis thaliana and its possible downstream 
target RD26. In our attempts to expressing and purify the FERONIA sensory domain in 
prokaryotic host Escherichia coli, the recombinant proteins failed to maintain its 
structural integrity and were unable to be recovered by protein refolding methods. The 
expression tests in yeast expression system Pichia pastoris have shown that the sensory 
domain was modified by PTM but low yield, suggesting the need for more sophisticated 
expression host, such as insect cell or tobacco, for producing well-folded and 
homogenous protein for crystallization. On the other hand, we crystallized the FERONIA 
kinase domain and RD26 DNA binding domain but with poor diffraction. Considerable 
efforts are still being made in our lab for optimizing the crystal conditions.  
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       To understand how FERONIA triggers the kinase activities at its C-terminus after 
receiving signal at sensory domain, it is crucial to acquire the structural information of 
the full-length protein. Unfortunately, crystallization of proteins with high flexibility as 
well as large protein complexes is almost an impossible task. Single particle cryo-
electron microscopy (cryo-EM), on the other hand, is able to image protein structure 
directly without crystallizing it. This technique was limited by poor resolution data 
acquisition. However, due to the recent developments of the detector and data processing, 
single particle cryo-EM is now able to elucidate the protein structural information to 
atomic level and thus it could be the ultimate approach for revealing the overall structure 
of FERONIA. 
 
